Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-cfpbc Total loading time: 0 Render date: 2024-04-25T03:46:35.126Z Has data issue: false hasContentIssue false

References

Published online by Cambridge University Press:  06 August 2009

Michael G. Sargent
Affiliation:
National Institute for Medical Research, London
Get access
Type
Chapter
Information
Biomedicine and the Human Condition
Challenges, Risks, and Rewards
, pp. 321 - 340
Publisher: Cambridge University Press
Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Harpending, H., and Rogers, A. (2000) Genetic perspectives on human origins and differentiation. Ann. Rev. Genomics Hum. Genet. 1, 361–85CrossRefGoogle Scholar
Haviland, W. (2000) Human evolution and prehistory. Harcourt
Neiburger, E. J. (2000) Dentistry in ancient Mesopotamia. J. Mass. Dent. Soc. 49, 16–19Google ScholarPubMed
Keynes, R. (2002) Annie's Box. Fourth Estate
Coale, A. J. (1974) The history of the human population. Sci. Am. 231, 41CrossRefGoogle ScholarPubMed
Eaton, S. B., and Konner, M. (1985) Palaeolithic nutrition: A consideration of its nature and current implications. N. Engl. J. Med. 312, 283–9CrossRefGoogle Scholar
McClaren, A. (1978) Birth control in nineteenth century England. Croom Helm
Hardy, A. (2001) Health and medicine in Britain since 1860. Palgrave
Riley, J. (2001) Rising life expectancy: a global history. Cambridge University Press
Fisher, D. (1978) The Rockefeller Foundation and the development of scientific medicine in Great Britain. Minerva 16, 20–41CrossRefGoogle ScholarPubMed
Tomes, N. (1998) The gospel of germs: Men, women, and the microbe in American life. Harvard University Press
Miles, A. (1966) The Lister Institute of Preventive Medicine 1891–1966. Nature 212, 559CrossRef
Medawar, P. B. (1963) The MRC fifty years ago and now. Nature 200, 1039–43CrossRefGoogle Scholar
Tuchman, B. (1962) The proud tower. MacMillan
Austoker, J. (1988) A history of the Imperial Cancer Research Fund, 1902–1986. Oxford University Press
Hare, R. (1970) The birth of penicillin. Allen and Unwin
Fosdick, R. (1952) The history of the Rockefeller Foundation. Harper
Corner, G. (1964) A history of the Rockefeller Institute. Rockefeller University Press
Edwards, R., and Steptoe, P. (1980) A matter of life. Hutchinson
Perut, M. F. (1999) Will medicine outgrow support? Nature 399, 299CrossRefGoogle Scholar
Abelson, P. (1968) The advancement of the nation's health. Science 158, 51Google Scholar
Strickland, S. (1971) Integration of medical research and health policies. Science 173, 1093CrossRefGoogle ScholarPubMed
Editorial. (1965) Does the United States have a science policy? Nature 217, 225–31
Kornberg, A. (1987) The NIH did it! Science 278, 1863CrossRefGoogle Scholar
Strauss, S. (2000) www:nccam.nih.gov/ne/testimony/houseoflords.html
Doll, R. (1992) Sir Austin Bradford Hill and the progress of medical science. BMJ 305, 1521CrossRefGoogle Scholar
Obituary. (2003) Louis Lasagna. BMJ 327, 565CrossRef
Lewin, B. (1970) Second golden age of molecular biology. Nature 227, 1009–13CrossRefGoogle ScholarPubMed
Smith, F. B. (1979) The peoples health 1830–1910. Holmes and Meier
Diamond, J. (1998) Guns, Germs, and Steel. Vintage
Shaw, G. B. (1911) Preface to The Doctors Dilemma. Penguin
Rosenberg, D., and Bloom, H. (1990) The Story of J. Faber and Faber
Youngson, A. J. (1979) The scientific revolution in Victorian medicine. Holmes and Meier
Loudon, I. (1992) The transformation of maternal mortality. BMJ 305, 1557CrossRefGoogle ScholarPubMed
Rosenberg, K. R., and Trevathan, W. R. (2001) The evolution of human birth. Sci. Am. 285, 72–7CrossRefGoogle ScholarPubMed
Cohen, J. (1996) Doctor James Young Simpson, Rabbi Abraham de Sola and Genesis Chapter 3, Verse 16. Obstetrics and Gynaecology 88, 895CrossRefGoogle Scholar
Caton, D. (1996) Who said childbirth is natural? The medical mission of Grantly Dick Read. Anaesthesiology 84, 955–64CrossRefGoogle ScholarPubMed
Behague, D. P., Victora, C. G., and Barros, F. C. (2002) Consumer demand for caesarean sections in Brazil. BMJ 324, 942–5CrossRefGoogle Scholar
Short, R. V. (1976) The evolution of human reproduction. Proc. Roy. Soc. B. 195, 3CrossRefGoogle ScholarPubMed
May, R. (1978) Human reproduction reconsidered. Nature 272, 491–5CrossRefGoogle ScholarPubMed
Tanner, J. (1989) Foetus into man: Physical growth from conception to maturity. Castlemead
Short, R. (1984) Breast feeding. Sci. Am. 250, 23CrossRefGoogle ScholarPubMed
Mepham, T. B. (1993) “Humanizing” milk: The formulation of artificial feeds for infants (1850–1910). Med. Hist. 37, 225–49CrossRefGoogle Scholar
Smith, E. (1988) The retreat of tuberculosis, 1850–1950. Croom Helm
Cuthbertson, W. (2000) Evolution of infant nutrition. Brit. J. Nut. 81, 359–371Google Scholar
Forsyth, J.. (2003) Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: Follow up of a randomised controlled trial. BMJ 326, 958–62CrossRefGoogle ScholarPubMed
McNeill, W. (1976) Plagues and peoples. Basil Blackwell
CIA (2002) World Fact Book. www.cia.gov
Langer, W. (1974) Infanticide: A historical survey. Hist. Child. Q. (Winter), 353–66Google ScholarPubMed
Parliament. (1999) House of Commons research paper 99/111. House of Commons
McKeown, T. (1988) The origins of human disease. Basil Blackwell
Halsey, A. (1972) Trends in British society since 1900. Macmillan
Stevenson, J. (1984) British society 1914–45. Penguin
Djerassi, C. (1962) The Pill, pygmy chimps, and Degas' horse. Basic Books
Wardell, D. (1980) Margaret Sanger: Birth control's successful revolutionary. Am. J. Public Health 70, 736–42CrossRefGoogle Scholar
Black, I. (2002) EU replaces cash denied to UN family planning by US. The Guardian, London, July 24
Harris, J. (1992) Clones, genes, and immortality
Editorial. (1968) Ethics and abortion. BMJ 2, 3CrossRef
Paintin, D. (1985) Legal abortion in England and Wales. CIBA Foundation Symposium 115, 4–20Google ScholarPubMed
Ho, P. C. (2000) Emergency contraception: Methods and efficacy. Curr. Opin. Obstet. Gynecol. 12, 175–9CrossRefGoogle ScholarPubMed
Ullman, A. (2000) The development of Mifepristone: A pharmaceutical drama in three acts. Am. Med. Women's Ass. 55 (suppl.) 117–120Google Scholar
Kolata, G. (1978) In vitro fertilization: Is it safe and repeatable? Science 201, 698Google ScholarPubMed
Trounson, A. L. J., Wood, C., Webb, J., and Wood, J. (1981) Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science 212, 681–2CrossRefGoogle ScholarPubMed
Edwards, R., and Steptoe, P. (1983) Current status of in-vitro fertilisation and implantation of human embryos. The Lancet 2, 1265–9CrossRefGoogle ScholarPubMed
Tesarik, J., and Mendoza, C. (1999) In vitro fertilization by intracytoplasmic sperm injection. Bioessays 21, 791–8013.0.CO;2-Z>CrossRefGoogle ScholarPubMed
Powell, K. (2003) Seeds of doubt. Nature 422, 656–8CrossRefGoogle Scholar
Gosden, R. (1999) Designer babies. Phoenix
Porcu, E.. (2000) Clinical experience and applications of oocyte cryopreservation. Mol. Cell. Endocrinol. 169, 33–7CrossRefGoogle ScholarPubMed
Harris, R. (2002) Human babies in germ-line juggernaut. Current Biology 11, R539–40CrossRefGoogle Scholar
Editorial. (1985) Powell bites dust: The British government needs to think hard about surrogacy. Nature 314, 568CrossRef
Stromberg, B.. (2002) Neurological sequelae in children born after in-vitro fertilisation: A population-based study. Lancet 359, 461–5CrossRefGoogle ScholarPubMed
Silver, L. (1998) Remaking Eden: Cloning, genetic engineering and the future of humankind? Phoenix
McCarty, M. (1985) The transforming principle. Norton
Judson, T. (1979) The eighth day of creation. Jonathan Cape
Olby, R. (2003) Quiet debut of the double helix. Nature 421, 402–5CrossRefGoogle ScholarPubMed
Crick, F. (1993) Looking backwards: A birthday card for the double helix. Gene 135, 15–18CrossRefGoogle ScholarPubMed
Griffith, J. S. (1967) Self-replication and scrapie. Nature 215, 1043–4CrossRefGoogle ScholarPubMed
Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. USA 95, 13363–83CrossRefGoogle ScholarPubMed
Melov, S.. (1999) Mitochondrial DNA rearrangements in ageing human brain and in situ PCR of mtDNA. Neurology. Ageing 20, 565–71CrossRefGoogle ScholarPubMed
Wallace, D. C. (1997) Mitochondrial DNA in ageing and disease. Sci. Am. 277, 40–7CrossRefGoogle ScholarPubMed
Gemmell, N. J., and Sin, F. Y. (2002) Mitochondrial mutations may drive Y chromosome evolution. Bioessays 24, 275–9CrossRefGoogle ScholarPubMed
Ponamarev, M. V.. (2002) Active site mutation in DNA polymerase gamma associated with progressive external ophthalmoplegia causes error-prone DNA synthesis. J. Biol. Chem. 277, 15225–8CrossRefGoogle ScholarPubMed
Melton, L. (2000) Womb wars. Sci. Am. 283, 24, 26CrossRefGoogle ScholarPubMed
Yu, N.. (2002) Disputed maternity leading to identification of tetragametic chimerismN. Engl. J. Med. 346, 1545–52CrossRefGoogle ScholarPubMed
Monod, J. (1972) Chance and Necessity. Collins
Crow, J. F. (1997) The high spontaneous mutation rate: Is it a health risk? Proc. Natl. Acad. Sci. USA 94, 8380–6CrossRefGoogle ScholarPubMed
Friedberg, E. C. (2001) How nucleotide excision repair protects against cancer. Nature Rev. Cancer 1, 22–33CrossRefGoogle ScholarPubMed
Bartek, J., and Lukas, J. (2003) Damage alert. Nature 421, 486–7CrossRefGoogle ScholarPubMed
Crow, J. F. (2000) The origins, patterns and implications of human spontaneous mutation. Nat. Rev. Genet. 1, 40–7CrossRefGoogle ScholarPubMed
Deininger, P. L., and Batzer, M. A. (1999) Alu repeats and human disease. Mol. Genet. Metab. 67, 183–93CrossRefGoogle ScholarPubMed
Li, X.. (2001) Frequency of recent retrotransposition events in the human factor IX gene. Hum. Mutat. 17, 511–19CrossRefGoogle ScholarPubMed
International Human Genome Sequencing Consortium. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860–921CrossRef
Greaves, M. (2002) Childhood leukaemia. BMJ 324, 283–7CrossRefGoogle ScholarPubMed
Nekrutenko, A., and Li, W. H. (2001) Transposable elements are found in a large number of human protein-coding genes. Trends Genet. 17, 619–21CrossRefGoogle Scholar
Smit, A. F. (1999) Interspersed repeats and other mementoes of transposable elements in mammalian genomes. Curr. Opin. Genet. Dev. 9, 657–63CrossRefGoogle Scholar
Symer, D. (2002) Human L1 retrotransposition is associated with genetic instability in vivo. Cell 110, 327–8CrossRefGoogle ScholarPubMed
Hughes, V. M., and Datta, N. (1983) Conjugative plasmids in bacteria of the ‘pre-antibiotic’ era. Nature 302, 725–6CrossRefGoogle ScholarPubMed
Karaolis, D. K., Lan, R., Kaper, J. B., and Reeves, P. R. (2001) Comparison of Vibrio cholerae pathogenicity islands in sixth and seventh pandemic strains. Infect. Immun. 69, 1947–52CrossRefGoogle ScholarPubMed
Stephens, C. and Murray, W. (2001) Pathogen evolution: How good bacteria go bad, Curr Biol 11, R53–6CrossRefGoogle ScholarPubMed
Groisman, E. A., and Ochman, H. (1997) How Salmonella became a pathogen. Trends Microbiol. 5, 343–9CrossRefGoogle ScholarPubMed
Herskind, A. M.. (1996) The heritability of human longevity: A population-based study of 2872 Danish twin pairs born 1870–1900. Hum. Genet. 97, 319–23CrossRefGoogle ScholarPubMed
Iachine, I. A.. (1998) How heritable is individual susceptibility to death? The results of an analysis of survival data on Danish, Swedish and Finnish twins. Twin Res. 1, 196–205CrossRefGoogle ScholarPubMed
Lichtenstein, P.. (2000) Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78–85CrossRefGoogle Scholar
Weatherall, D. (1991) The new genetics and clinical practice. Oxford University Press
Marx, J. (2002) Unravelling the cause of diabetes. Science 296, 686–9CrossRefGoogle Scholar
Cole, T. J. (2000) Secular trends in growth. Proc. Nutr. Soc. 59, 317–24CrossRefGoogle ScholarPubMed
Brundtland, G. H., Liestol, K., and Walloe, L. (1980) Height, weight and menarcheal age of Oslo schoolchildren during the last 60 years. Ann. Hum. Biol. 7, 307–22CrossRefGoogle ScholarPubMed
Floud, R., Wachter, K., and Gregory, A. (1990) Height, health and history. Cambridge University Press
Wilmoth, J. R., Deegan, L. J., Lundstrom, H., and Horiuchi, S. (2000) Increase of maximum life-span in Sweden, 1861–1999. Science 289, 2366–8CrossRefGoogle Scholar
Alberts, B., et al., (2002) The molecular biology of the cell. Garland
Ridley, M. (2003) Nature via nurture. Fourth Estate
Porter, R. (1997) The greatest benefit to mankind. Oxford University Press
Masutomi, K.. (2003) Telomerase maintains telomere structure in normal human cells. Cell 114, 241–53CrossRefGoogle ScholarPubMed
Wong, J. M., and Collins, K. (2003) Telomere maintenance and disease. Lancet 362, 983–8CrossRefGoogle ScholarPubMed
Cohen, M., Lee, K. K., Wilson, K. L., and Gruenbaum, Y. (2001) Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. Trends Biochem. Sci. 26, 41–7CrossRefGoogle ScholarPubMed
Yaffe, M. (1999) The machinery of mitochondrial inheritance and behaviour. Science 283, 1493–7CrossRefGoogle Scholar
Wallace, D. C. (1999) Mitochondrial diseases in man and mouse. Science 283, 1482–8CrossRefGoogle Scholar
Marchington, D. R.. (1998) Evidence from human oocytes for a genetic bottleneck in an mtDNA disease. Am. J. Hum. Genet. 63, 769–75CrossRefGoogle Scholar
Larson, J. E., and Cohen, J. C. (2000) Cystic fibrosis revisited. Mol. Genet. Metab. 71, 470–7CrossRefGoogle ScholarPubMed
McNeil, P., Miyake, K., and Vogel, S. (2003) The endomembrane requirement for cell surface repair. PNAS 100, 4592–7CrossRefGoogle ScholarPubMed
Brady, S. T. (1993) Motor neurons and neurofilaments in sickness and in health. Cell 73, 1–3CrossRefGoogle ScholarPubMed
Winchester, B., Vellodi, A., and Young, E. (2000) The molecular basis of lysosomal storage diseases and their treatment. Biochem. Soc. Trans. 28, 150–4CrossRefGoogle ScholarPubMed
Keller, J., Gee, J., and Ding, Q. (2002) The proteasome in brain ageing. Ageing Res. Rev. 1, 279–93CrossRefGoogle Scholar
Wilmut, I.. (1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810–13CrossRefGoogle ScholarPubMed
Levi-Montalcini, R. (1987) The nerve growth factor 35 years later. Science 237, 1154–62CrossRefGoogle ScholarPubMed
Jacobson, M. D., Weil, M., and Raff, M. C. (1997) Programmed cell death in animal development. Cell 88, 347–54CrossRefGoogle ScholarPubMed
Raff, M. C. (1992) Social controls on cell survival and cell death. Nature 356, 397–400CrossRefGoogle ScholarPubMed
Krammer, P. H. (2000) CD95's deadly mission in the immune system. Nature 407, 789–95CrossRefGoogle ScholarPubMed
Hetts, S. W. (1998) To die or not to die: An overview of apoptosis and its role in disease. JAMA 279, 300–7CrossRefGoogle ScholarPubMed
Fleisher, T. A., Straus, S. E., and Bleesing, J. J. (2001) A genetic disorder of lymphocyte apoptosis involving the fas pathway: The autoimmune lymphoproliferative syndrome. Curr. Allergy Asthma Rep. 1, 534–40CrossRefGoogle ScholarPubMed
Niederkorn, J. Y. (1999) The immune privilege of corneal allografts. Transplantation 67, 1503–8CrossRefGoogle ScholarPubMed
Uckan, D.. (1997) Trophoblasts express Fas ligand: A proposed mechanism for immune privilege in placenta and maternal invasion. Mol. Hum. Reprod. 3, 655–62CrossRefGoogle ScholarPubMed
Brash, D. (1996) Cellular proofreading. Nature Medicine 2, 525–6CrossRefGoogle ScholarPubMed
Fadeel, B., Orrenius, S., and Zhivotovsky, B. (1999) Apoptosis in human disease: A new skin for the old ceremony? Biochem. Biophys. Res. Commun. 266, 699–717CrossRefGoogle ScholarPubMed
Levine, A. (1997) p53 the cellular gatekeeper for growth and division. Cell 88, 323–31CrossRefGoogle ScholarPubMed
Hayflick, L. (1994) How and why we age. Ballantine Books
Ferri, K. F., and Kroemer, G. (2001) Mitochondria – the suicide organelles. Bioessays 23, 111–153.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Fuchs, E. (1997) Of mice and men: Genetic disorders of the cytoskeleton (Keith R. Porter Lecture, 1996). Mol. Biol. Cell 8, 189–203CrossRefGoogle Scholar
Nicklas, R. B. (1997) How cells get the right chromosomes. Science 275, 632–7CrossRefGoogle ScholarPubMed
Dynes, M. (2003) Miracle birth of the elusive baby found growing on mother's liver. The Times, May 24
Nilsson, L. (1990) A child is born. Dell
Brent, L., and Owen, R. (1996) A history of transplantation immunology. Academic Press
Barinaga, M. (2002) Cells exchanged during pregnancy live on. Science 296, 2169–72CrossRefGoogle Scholar
Barker, D. (1998) Mothers, babies and health in later life. Churchill Livingston
Wolpert, L. (1991) The triumph of the embryo. Oxford University Press
Qumsiyeh, M. B., Kim, K. R., Ahmed, M. N., and Bradford, W. (2000) Cytogenetics and mechanisms of spontaneous abortions: Increased apoptosis and decreased cell proliferation in chromosomally abnormal villi. Cytogenet. Cell Genet. 88, 230–5CrossRefGoogle ScholarPubMed
Griffin, D. K. (1996) The incidence, origin, and etiology of aneuploidy. Int. Rev. Cytol. 167, 263–96CrossRefGoogle ScholarPubMed
Norimura, T.. (1996) p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat. Med. 2, 577–80CrossRefGoogle ScholarPubMed
Heyer, B. S., MacAuley, A., Behrendtsen, O., and Werb, Z. (2000) Hypersensitivity to DNA damage leads to increased apoptosis during early mouse development. Genes Dev. 14, 2072–84Google ScholarPubMed
Stewart, R. J., Sheppard, H., Preece, R., and Waterlow, J. C. (1980) The effect of rehabilitation at different stages of development of rats marginally malnourished for ten to twelve generations. Br. J. Nutr. 43, 403–12CrossRefGoogle ScholarPubMed
Gluckman, P. D. (2001) Editorial: Nutrition, glucocorticoids, birth size, and adult disease. Endocrinology 142, 1689–91CrossRefGoogle ScholarPubMed
Lumbers, E. R., Yu, Z. Y., and Gibson, K. J. (2001) The selfish brain and the Barker hypothesis. Clin. Exp. Pharmacol. Physiol. 28, 942–7CrossRefGoogle ScholarPubMed
Garofano, A., Czernichow, P., and Breant, B. (1997) In utero undernutrition impairs rat beta-cell development. Diabetologia 40, 1231–4CrossRefGoogle ScholarPubMed
Kwong, W. Y.. (2000) Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development 127, 4195–202Google ScholarPubMed
Butterworth, C. E. Jr., and Bendich, A. (1996) Folic acid and the prevention of birth defects. Ann. Rev. Nutr. 16, 73–97CrossRefGoogle ScholarPubMed
Biever, C. (2003) Bring me sunshine. The New Scientist 179, 30–1Google Scholar
van der Meulen, J., et al. (1999) Fetal programming associated with the Dutch famine 1944–5. In Fetal Programming: Influences on Development and Disease in Later Life, ed. P. O'Brien, T. Wheeler, and D. J. P. Barker. Royal College of Obstetricians and Gynaecologists, pp. 45–56
Stein, Z., Susser, M., Saenger, G., and Marolla, F. (1975) Famine and human development: The Dutch hunger winter of 1944–1945. Oxford University Press
Boyd-Orr, J. (1936) Food, health and income. Macmillan
Eriksson, J.. (1999) Catch-up growth in childhood and death from coronary heart disease: Longitudinal study. BMJ 318, 427–31CrossRefGoogle ScholarPubMed
Trowell, H., and Burkitt, D. (1981) Western diseases, their emergence and prevention. Harvard University Press
Diamond, J. (2003) The double puzzle of diabetes. Nature 423, 599–602CrossRefGoogle ScholarPubMed
Prentice, A. (2003) Intrauterine factors, adiposity and hyperinsulinaemia. BMJ 327, 880–1CrossRefGoogle ScholarPubMed
Porter, D. (1999) Health, civilisation and the state. Routledge
Le Fanu, J. (1999) The rise and fall of modern medicine. Little, Brown
Osmond, C., and Barker, D. J. (2000) Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ. Health. Perspect. 108 (suppl. 3) 545–53CrossRefGoogle ScholarPubMed
Chandra, R. K. (1991) Interactions between early nutrition and the immune system. Ciba. Found. Symp. 156, 77–89Google ScholarPubMed
Moore, S. E.. (1997) Season of birth predicts mortality in rural Gambia. Nature 388, 434CrossRefGoogle ScholarPubMed
Stephens, T., and Brynner, R. (2001) Dark remedy: The impact of thalidomide and its revival as a vital medicine. Perseus
Colborn, T., Dumanoski, D., and Myers, J. (1997) Our stolen future. Abacus
Ibarreta, D. and Swan, S. (2002) The DES story: Long term consequences of prenatal exposure. In The Precautionary Principle in the 20th Century: Late Lessons from Early Warnings, ed. Poul Harremoës et al. European Environment Agency, pp. 90–9
Kaiser, J. (2000) Endocrine disrupters: Panel cautiously confirms low-dose effects. Science 290, 695–7CrossRefGoogle ScholarPubMed
Hunt, P. A.. (2003) Bisphenol exposure causes meiotic aneuploidy in the female mouse. Curr. Biol. 13, 546–53CrossRefGoogle ScholarPubMed
Rennie, J. (1996) Perinatal management of the lower margin of viability. Arch. Dis. Child 74, F214–F218CrossRefGoogle ScholarPubMed
Christie, B. (2000) Premature babies have high death and disability rate. BMJ 321, 467CrossRefGoogle ScholarPubMed
Wickelgren, I. (2004) Resetting pregnancy's clock. Science 304, 666–8CrossRefGoogle ScholarPubMed
Tin, W., Wariyar, U., and Hey, E. (1997) Changing prognosis for babies of less than 28 weeks' gestation in the north of England between 1983 and 1994. BMJ 314, 107–11CrossRefGoogle ScholarPubMed
Avery, M. E. (2000) Surfactant deficiency in hyaline membrane disease: The story of discovery. Am. J. Respir. Crit. Care Med. 161, 1074–5CrossRefGoogle Scholar
Uauy, R., and Hoffman, D. (2003) Essential fat requirements of preterm infants., Am. J. Clin. Nutr. 71, 245–50CrossRefGoogle Scholar
Field, T. (1988) Stimulation of preterm infants. Pediatr. Rev. 10, 149–53CrossRefGoogle ScholarPubMed
Schanberg, S. M., and Field, T. M. (1987) Sensory deprivation stress and supplemental stimulation in the rat pup and preterm human neonate. Child Dev. 58, 1431–47CrossRefGoogle ScholarPubMed
Hack, M., and Merkatz, I. R. (1995) Preterm delivery and low birth weight – a dire legacy. N. Engl. J. Med. 333, 1772–4CrossRefGoogle ScholarPubMed
Liu, Y., Albertsson-Wikland, K., and Karlberg, J. (2000) Long-term consequences of early linear growth retardation (stunting) in Swedish children. Pediatr. Res. 47, 475–80CrossRefGoogle Scholar
Karlberg, J., and Luo, Z. C. (2000) Foetal size to final height. Acta Paediatr. 89, 632–6CrossRefGoogle ScholarPubMed
Bogin, B. (1999) Patterns of human growth. Cambridge University Press
Janeway, C. A. Jr. (2001) How the immune system works to protect the host from infection: A personal view. Proc. Natl. Acad. Sci. USA 98, 7461–8CrossRefGoogle ScholarPubMed
Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415, 389–95CrossRefGoogle ScholarPubMed
Carswell, E. A.. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666–70CrossRefGoogle ScholarPubMed
McCormick, J. K., Yarwood, J. M., and Schlievert, P. M. (2001) Toxic shock syndrome and bacterial superantigens: An update. Ann. Rev. Microbiol. 55, 77–104CrossRefGoogle ScholarPubMed
Libby, P. (2002) Atherosclerosis: The new view. Sci. Am. 286, 46–55CrossRefGoogle ScholarPubMed
Yazdanbakhsh, M., Kremsner, P. G., and Ree, R. (2002) Allergy, parasites, and the hygiene hypothesis. Science 296, 490–4CrossRefGoogle ScholarPubMed
Martinez, F. D., and Holt, P. G. (1999) Role of microbial burden in aetiology of allergy and asthma. Lancet 354 (suppl. 2). SII12–15CrossRefGoogle ScholarPubMed
Mackay, I. R. (2000) Tolerance and autoimmunity. BMJ 321, 93–6CrossRefGoogle ScholarPubMed
Goldbach-Mansky, R., and Lipsky, P. E. (2003) New concepts in the treatment of rheumatoid arthritis. Ann. Rev. Med. 54, 197–216CrossRefGoogle ScholarPubMed
Todd, J. A. (2001) Human genetics: Tackling common disease. Nature 411, 537, 539CrossRefGoogle ScholarPubMed
Ye, X.. (2000) Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science 287, 303–5CrossRefGoogle ScholarPubMed
Rajakumar, K. (2000) Pellagra in the United States: A historical perspective. South. Med. J. 93, 272–7CrossRefGoogle ScholarPubMed
Chan, A. C. (1998) Vitamin E and atherosclerosis. J. Nutr. 128, 1593–6CrossRefGoogle ScholarPubMed
Bang, H. O., and Dyerberg, J. (1981) Personal reflections on the incidence of ischaemic heart disease in Oslo during the Second World War. Acta. Med. Scand. 210, 245–8CrossRefGoogle ScholarPubMed
Connor, W. E. (2000) Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 71, 171S–5SCrossRefGoogle ScholarPubMed
Lamartiniere, C. A. (2000) Protection against breast cancer with genistein: A component of soy. Am. J. Clin. Nutr. 71, 1705S–7S; discussion 1708S–9SCrossRefGoogle ScholarPubMed
Taubes, G. (2001) Nutrition: The soft science of dietary fat. Science 291, 2536–45CrossRefGoogle ScholarPubMed
Fahey, J. W., Zhang, Y., and Talalay, P. (1997) Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. USA 94, 10367–72CrossRefGoogle ScholarPubMed
Brosens, J., and Parker, M. (2003) Oestrogen receptor hikacked. Nature 423, 487–8CrossRefGoogle Scholar
Kogevinas, M. (2001) Human health effects of dioxins: Cancer, reproductive and endocrine system effects. Hum. Reprod. Update 7, 331–9CrossRefGoogle ScholarPubMed
Ames, B., Magaw, R., and Gold, L. (1987) Ranking possible carcinogenic hazards. Science 236, 271–280CrossRefGoogle ScholarPubMed
Janeway, C., Travers, P., Walport, M., and Shlomchik, M. (2001) Immunobiology. Garland Publishing
Tuljapurkar, S., Li, N., and Boe, C. (2000) A universal pattern of mortality decline in the G7 countries. Nature 405, 789–92CrossRefGoogle ScholarPubMed
Kirkwood, T. B., and Austad, S. N. (2000) Why do we age? Nature 408, 233–8CrossRefGoogle ScholarPubMed
Holliday, R. (1995) Understanding ageing. Cambridge University Press
Hayflick, L. (2000) The future of ageing. Nature 408, 267–9CrossRefGoogle ScholarPubMed
Davey, B., Halliday, T., and Hirst, M. (2001) Human biology and health: An evolutionary approach. Open University
Harman, D. (1956) Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 1956 11, 298–300CrossRefGoogle ScholarPubMed
Beckman, K. B., and Ames, B. N. (1998) The free radical theory of aging matures. Physiol. Rev. 78, 547–81CrossRefGoogle ScholarPubMed
Melov, S.. (2000) Extension of life-span with superoxide dismutase/catalase mimetics. Science 289, 1567–9CrossRefGoogle ScholarPubMed
McKenzie, D.. (2002) Mitochondrial DNA deletion mutations: A causal role in sarcopenia. Eur. J. Biochem. 269, 2010–15CrossRefGoogle ScholarPubMed
Brunk, U. T., and Terman, A. (2002) The mitochondrial-lysosomal axis theory of aging: Accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur. J. Biochem. 269, 1996–2002CrossRefGoogle ScholarPubMed
Suter, M.. (2000) Age-related macular degeneration: The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J. Biol. Chem. 275, 39625–30CrossRefGoogle ScholarPubMed
Dirks, A. and Leeuwenburgh, C. (2002) Apoptosis in skeletal muscle with aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R519–27CrossRefGoogle ScholarPubMed
Lamberts, S. W., Beld, A. W., and Lely, A. J. (1997) The endocrinology of aging. Science 278, 419–24CrossRefGoogle Scholar
Rudman, D.. (1990) Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323, 1–6CrossRefGoogle ScholarPubMed
Laron, Z. (2002) Effects of growth hormone and insulin-like growth factor 1 deficiency on ageing and longevity. Novartis Found. Symp. 242, 125–37; discussion 137–42Google ScholarPubMed
Yen, S. S. (2001) Dehydroepiandrosterone sulfate and longevity: New clues for an old friend. Proc. Natl. Acad. Sci. USA 98, 8167–9CrossRefGoogle ScholarPubMed
Lane, M. A., Ingram, D. K., Ball, S. S., and Roth, G. S. (1997) Dehydroepiandrosterone sulfate: A biomarker of primate aging slowed by calorie restriction. J. Clin. Endocrinol. Metab. 82, 2093–6CrossRefGoogle ScholarPubMed
Lord, J. M.. (2001) Neutrophil ageing and immunesenescence. Mech. Ageing Dev. 122, 1521–35CrossRefGoogle ScholarPubMed
Finkel, T., and Holbrook, N. J. (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408, 239–47CrossRefGoogle ScholarPubMed
Finch, C. E., and Tanzi, R. E. (1997) Genetics of aging. Science 278, 407–11CrossRefGoogle ScholarPubMed
Perls, T. T. (1995) The oldest old. Sci. Am. 272, 70–5CrossRefGoogle ScholarPubMed
Martin, G. M., and Oshima, J. (2000) Lessons from human progeroid syndromes. Nature 408, 263–6CrossRefGoogle ScholarPubMed
Hsin, H., and Kenyon, C. (1999) Signals from the reproductive system regulate the lifespan of C. elegans. Nature 399, 362–6CrossRefGoogle ScholarPubMed
Hamilton, M. L.. (2001) Does oxidative damage to DNA increase with age? Proc. Natl. Acad. Sci. USA 98, 10469–74CrossRefGoogle ScholarPubMed
Kayo, T., Allison, D. B., Weindruch, R., and Prolla, T. A. (2001) Influences of aging and caloric restriction on the transcriptional profile of skeletal muscle from rhesus monkeys. Proc. Natl. Acad. Sci. USA 98, 5093–8CrossRefGoogle ScholarPubMed
Cristofalo, V. J.. (1998) Relationship between donor age and the replicative lifespan of human cells in culture: A reevaluation, Proc. Natl. Acad. Sci. USA 95, 10614–9CrossRefGoogle Scholar
Faragher, R. G., and Kipling, D. (1998) How might replicative senescence contribute to human ageing? Bioessays 20, 985–913.0.CO;2-A>CrossRefGoogle ScholarPubMed
Kassem, M.. (1997) Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts. Osteoporosis Int. 7, 514–24CrossRefGoogle ScholarPubMed
Hayflick, L. (2002) DNA replication and traintracks. Science 296, 1611–12CrossRefGoogle ScholarPubMed
Zglinicki, T. (2001) Telomeres and replicative senescence: Is it only length that counts? Cancer Lett. 168, 111–16CrossRefGoogle Scholar
Shay, J. W., and Wright, W. E. (2001) Ageing and cancer: The telomere and telomerase connection. Novartis Found. Symp. 235, 116–25; discussion 125–9, 146–9Google ScholarPubMed
Johnson, F. B., Marciniak, R. A., and Guarente, L. (1998) Telomeres, the nucleolus and aging. Curr. Opin. Cell Biol. 10, 332–8CrossRefGoogle ScholarPubMed
Schwarcz, J. (2001) The genie in the bottle. Freeman
Lock, S. (1983) “O that I were young again”: Yeats and the Steinach operation. Br. Med. J. (Clin. Res. Ed.) 287, 1964–8CrossRefGoogle ScholarPubMed
Alcor Life Extension Foundation. (2000). www.alcor.org
deGrey, A.. (2003) Antiageing technology and pseudoscience. Science 296, 5568–9Google Scholar
Hall, S. (2003) In vivo vitalis? Compounds activate life-extending genes. Science 301, 1165CrossRef
Kirkwood, T. The time of our lives. Weidenfeld and Nicholson
Rettig, R. (1977) Cancer crusade. Princeton University Press
Weisburger, E. K. (1989) Current carcinogen perspectives: De minimis, Delaney and decisions. Sci. Total Environ. 86, 5–13CrossRefGoogle ScholarPubMed
Stehelin, D., Varmus, H. E., Bishop, J. M., and Vogt, P. K. (1976) DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260, 170–3CrossRefGoogle ScholarPubMed
Culliton, B. (1972) Cancer virus theories: Focus of research debate. Science 177, 44–7CrossRefGoogle ScholarPubMed
Peto, J. (2001) Cancer epidemiology in the last century and the next decade. Nature 411, 390–5CrossRefGoogle ScholarPubMed
Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57–70CrossRefGoogle ScholarPubMed
Look, A. (1997) Oncogenic transcription factors in the human acute leukaemias. Science 278, 1059–64CrossRefGoogle Scholar
Marx, J. (2003) Mutant stem cells may seed cancer. Science 301, 1308–10CrossRefGoogle ScholarPubMed
Campisi, J. (2000) Cancer, aging and cellular senescence. In Vivo 14, 183–8Google ScholarPubMed
Artandi, S. E., and DePinho, R. A. (2000) A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev. 10, 39–46CrossRefGoogle ScholarPubMed
Nordstrom, D. K. (2002) Public health. Worldwide occurrences of arsenic in ground water. Science 296, 2143–5CrossRefGoogle ScholarPubMed
Ames, B. N. (1979) Identifying environmental chemicals causing mutations and cancer. Science 204, 587–93CrossRefGoogle ScholarPubMed
Ohshima, H., and Bartsch, H. (1994) Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat. Res. 305, 253–64CrossRefGoogle ScholarPubMed
Iversen, L. (2001) Drugs: A very short introduction. Oxford University Press
Weinberg, R. (1997) Racing to the start of the road: The search for the origin of cancer. Bantam
Peto, R.. (1992) Mortality from tobacco in developed countries: Indirect estimation from national vital statistics. Lancet 339, 1268–78CrossRefGoogle ScholarPubMed
Kmietowicz, Z. (2001) Tobacco company claims that smokers help the economy. BMJ 323, 126CrossRefGoogle ScholarPubMed
Scotto, J., and Bailar, J. (1969) Rigoni-Stern and medical statistics: A nineteenth-century approach to cancer research. J. Hist. Med. Allied Sci. 24, 65–75CrossRefGoogle ScholarPubMed
Pierce, D. A.. (1996) Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950–1990. Radiat. Res. 146, 1–27CrossRefGoogle ScholarPubMed
Obituary. (2002) Dr. Alice Stewart. New York Times
Goldman, M. (1996) Cancer risk of low-level exposure. Science 271, 1821–2CrossRefGoogle ScholarPubMed
Coussens, L. M., and Werb, Z. (2002) Inflammation and cancer. Nature 420, 860–7CrossRefGoogle ScholarPubMed
Gee, D., and M. Greenberg. (2002) Asbestos: From ‘magic’ to malevolent mineral. In The Precautionary Principle in the 20th Century: Late Lessons from Early Warnings, ed. Poul Harremoës et al. European Environment Agency, pp. 49–63
Ferber, D. (2002) Virology: Monkey virus link to cancer grows stronger. Science 296, 1012–15CrossRefGoogle ScholarPubMed
Ames, B. N. (1999) Cancer prevention and diet: Help from single nucleotide polymorphisms. Proc. Natl. Acad. Sci. USA 96, 12216–8CrossRefGoogle ScholarPubMed
Blacklock, C. J.. (2001) Salicylic acid in the serum of subjects not taking aspirin: Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin. J. Clin. Pathol. 54, 553–5CrossRefGoogle Scholar
Doll, R., and Armstrong, B. (1980) Cancer. In Western Diseases, Their Emergence and Prevention, ed. H. Trowell and D. Burkitt. Harvard University Press, pp. 93–112
Leaf, C. (2004) Why we're losing the war on cancer and how to win. Fortune, March 22, 42–9
Drancourt, M., and Raoult, D. (2002) Molecular insights into the history of plague. Microbes Infect. 4, 105–9CrossRefGoogle ScholarPubMed
Halleyday, S. (1999) The great stink of London: Sir Joseph Bazalgette and the cleansing of the Victorian metropolis. Sutton Publishing
Daniel, T. M. (2000) The origins and precolonial epidemiology of tuberculosis in the Americas: Can we figure them out? Int. J. Tuberc. Lung Dis. 4, 395–400Google ScholarPubMed
Baxby, D. (1996) Two hundred years of vaccination. Curr. Biol. 6, 769–72CrossRefGoogle ScholarPubMed
Baker, J. P. (2000) Immunization and the American way: Four childhood vaccines. Am. J. Public Health. 90, 199–207Google Scholar
Vitek, C. R., and Wharton, M. (1998) Diphtheria in the former Soviet Union: Reemergence of a pandemic disease. Emerg. Infect. Dis. 4, 539–50CrossRefGoogle ScholarPubMed
Robertson, S. E.. (1996) Yellow fever: A decade of re-emergence. JAMA 276, 1157–62CrossRefGoogle Scholar
Meldrum, M. (1998) “A calculated risk”: The Salk polio vaccine field trials of 1954. BMJ 317, 1233–6CrossRefGoogle ScholarPubMed
Blume, S., and Geesink, I. (2000) A brief history of polio vaccines. Science 288, 1593–4CrossRefGoogle ScholarPubMed
Nathanson, N., and Fine, P. (2002) Virology: Poliomyelitis eradication–a dangerous endgame. Science 296, 269–70CrossRefGoogle ScholarPubMed
Weiss, R. A. (2001) Animal origins of human infectious disease (Leeuwenhoek Lecture 2001). Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356, 957–77CrossRefGoogle Scholar
Ferber, D. (2002) Public health: Creeping consensus on SV40 and polio vaccine. Science 298, 725–7CrossRefGoogle ScholarPubMed
Behr, M. A. (2001) Comparative genomics of BCG vaccines. Tuberculosis (Edinb.) 81, 165–8CrossRefGoogle ScholarPubMed
Weiner, D. B., and Kennedy, R. C. (1999) Genetic vaccines. Sci. Am. 281, 50–7CrossRefGoogle ScholarPubMed
Madsen, K. M.. (2002) A population-based study of measles, mumps, and rubella vaccination and autism. N. Engl. J. Med. 347, 1477–82CrossRefGoogle ScholarPubMed
Loudon, I. (1987) Puerperal fever, the streptococcus, and the sulphonamides, 1911–1945. BMJ 295, 485–490CrossRefGoogle ScholarPubMed
Levy, S. B. (1998) The challenge of antibiotic resistance. Sci. Am. 278, 46–53CrossRefGoogle ScholarPubMed
Ferber, D. (2003) WHO advises kicking the livestock antibiotic habit. Science 301, 1027CrossRefGoogle ScholarPubMed
Crisostomo, M. I.. (2001) The evolution of methicillin resistance in Staphylococcus aureus: Similarity of genetic backgrounds in historically early methicillin-susceptible and – resistant isolates and contemporary epidemic clones. Proc. Natl. Acad. Sci. USA 98, 9865–70CrossRefGoogle ScholarPubMed
Ferber, D. (2002) Livestock feed ban preserves drug's power. Science 295, 27–8CrossRefGoogle Scholar
Clarke, T. (2003) Drug companies snub antibiotics as pipeline threatens to run dry. Nature 425, 225CrossRefGoogle ScholarPubMed
Reid, S. D.. (2000) Parallel evolution of virulence in pathogenic Escherichia coli. Nature 406, 64–7CrossRefGoogle ScholarPubMed
Eisen, J. A. (2001) Gastrogenomics. Nature 409, 463, 465–6CrossRefGoogle ScholarPubMed
Pupo, G. M., Lan, R., and Reeves, P. R. (2000) Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics. Proc. Natl. Acad. Sci. USA 97, 10567–72CrossRefGoogle ScholarPubMed
Starr, D. (1999) Blood. Warner
Defrancesco, L. (2002) US in grip of West Nile Virus. Nature Medicine 8, 1051CrossRefGoogle ScholarPubMed
Cyranoski, D., and Abbott, A. (2003) Virus detectives seek source of SARS in China's wild animals. Nature 423, 467CrossRefGoogle ScholarPubMed
Balter, M. (2000) Emerging diseases: On the trail of Ebola and Marburg viruses. Science 290, 923–5CrossRefGoogle ScholarPubMed
Berche, P. (2001) The threat of smallpox and bioterrorism. Trends Microbiol. 9, 15–18CrossRefGoogle ScholarPubMed
Cosby, A. (1989) America's forgotten pandemic. Cambridge University Press
Taubenberger, J. K., Reid, A. H., and Fanning, T. G. (2000) The 1918 influenza virus: A killer comes into view. Virology 274, 241–5CrossRefGoogle ScholarPubMed
Webster, R. (2001) A molecular whodunit. Science 293, 1773–5Google ScholarPubMed
Shortridge, K. F. (1999) The 1918 ‘Spanish’ flu: Pearls from swine? Nat. Med. 5, 384–5CrossRefGoogle ScholarPubMed
Kilbourne, E. D. (1997) In pursuit of influenza: Fort Monmouth to Valhalla (and back). Bioessays 19, 641–50CrossRefGoogle Scholar
Pruisner, S., Montaingner, L., and Gallo, R. (2002) Discovering the cause of AIDS. Science 298, 1726–31CrossRefGoogle Scholar
Hillis, D. (2000) Origins of HIV. Science 288, 1757–8CrossRefGoogle ScholarPubMed
Marx, P., Alcabes, P., and Drucker, E. (2001) Serial human passage of simian immunodeficiency virus by unsterile injections and the emergence of epidemic HIV in Africa. Phil. Trans. Roy. Soc. 356, 911–20CrossRefGoogle ScholarPubMed
Hooper, E., (2000) The river: A journey back to the source of HIV and AIDS. Penguin
Weiss, R. A. (2001) Polio vaccines exonerated. Nature 410, 1035–6CrossRefGoogle ScholarPubMed
Richman, D. D. (2001) HIV chemotherapy. Nature 410, 995–1001CrossRefGoogle ScholarPubMed
Weller, I. V., and Williams, I. G. (2001) ABC of AIDS: Antiretroviral drugs. BMJ 322, 1410–12CrossRefGoogle ScholarPubMed
Collinge, J. (1999) Variant Creutzfeldt-Jakob disease. Lancet 354, 317–23CrossRefGoogle ScholarPubMed
Zobeley, E.. (1999) Infectivity of scrapie prions bound to a stainless steel surface. Mol. Med. 5, 240–3Google ScholarPubMed
Sun, M. (1985) Gene-spliced hormone for growth approved. Science 230, 523CrossRefGoogle ScholarPubMed
Ghani, A. C., Ferguson, N. M., Donnelly, C. A., and Anderson, R. M. (2003) Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK. Proc. R. Soc. Lond. B. Biol. Sci. 270, 689–98CrossRefGoogle ScholarPubMed
Mead, S., Stumpf, M., and Whitfield, J. (2003) Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300, 640–3CrossRefGoogle ScholarPubMed
Carter, R., and Mendis, K. N. (2002) Evolutionary and historical aspects of the burden of malaria. Clin. Microbiol. Rev. 15, 564–94CrossRefGoogle ScholarPubMed
Spielman, A., and D'Antonio, M. (2001) Mosquito: The story of mans deadliest foe. Faber and Faber
Gubler, D. J., (2004) Cities spawn epidemic dengue viruses. Nature, Medicine 10, 129–30CrossRefGoogle ScholarPubMed
Packard, R. M., and Gadehla, P. (1997) A land filled with mosquitoes: Fred L. Soper, the Rockefeller Foundation, and the anopheles gambiae invasion of Brazil. Med. Anthropol. 17, 215–38CrossRefGoogle Scholar
Zajtchuk, R. (1997) Textbook of military medicine: Medical aspects of chemical and biological warfare. http://www.vnh.org/MedAspChemBioWar/ chapters
Meselson, M.. (1994) The Sverdlovsk anthrax outbreak of 1979. Science 266, 1202–8CrossRefGoogle ScholarPubMed
Henderson, D. A. (1999) The looming threat of bioterrorism. Science 283, 1279–82CrossRefGoogle ScholarPubMed
Check, E. (2002) Poliovirus advance sparks fears of data curbs. Nature 418, 265Google ScholarPubMed
Sneador, W. (1985) Drug discovery: The evolution of modern medicines. Wiley
Tulp, M., and Bohlin, L. (2002) Functional versus chemical diversity: Is biodiversity important for drug discovery? Trends Pharmacol. Sci. 23, 225–31CrossRefGoogle ScholarPubMed
Plunkett, M. J., and Ellman, J. A. (1997) Combinatorial chemistry and new drugs. Sci. Am. 276, 68–73CrossRefGoogle ScholarPubMed
Moellering, R. C. Jr. (1999) A novel antimicrobial agent joins the battle against resistant bacteria. Ann. Intern. Med. 130, 155–7CrossRefGoogle ScholarPubMed
Haseltine, W. A. (2001) Beyond chicken soup. Sci. Am. 285, 56–63CrossRefGoogle ScholarPubMed
Fabbro, D.. (2002) Protein kinases as targets for anticancer agents: From inhibitors to useful drugs. Pharmacol. Ther. 93, 79–98CrossRefGoogle ScholarPubMed
Pfeffer, N. (1993) The stork and the syringe: A political history of reproductive medicine. Polity Press
Pilcher, H. (2003) The ups and downs of Lithium. Nature 425, 118–120CrossRefGoogle ScholarPubMed
Healy, D. (2003) The creation of psychopharmacology. Harvard University Press
Bodenheimer, T. (2000) Uneasy alliance – clinical investigators and the pharmaceutical industry. N. Engl. J. Med. 342, 1539–44CrossRefGoogle ScholarPubMed
Dyer, O. (2001) University accused of violating academic freedom to safeguard funding from drug companies. BMJ 323, 591CrossRefGoogle ScholarPubMed
Safer, D. J. (2000) Are stimulants overprescribed for youths with ADHD?Ann. Clin. Psychiatry 12, 55–62CrossRefGoogle ScholarPubMed
Vane, J. (1994) Towards a better aspirin. Nature 367, 215–16CrossRefGoogle ScholarPubMed
Editorial. (2003) How a statin might destroy a drug company. The Lancet 361, 793CrossRef
Henry, D., and Lexchin, J. (2002) The pharmaceutical industry as a medicines provider. The Lancet 16, 1590–5CrossRefGoogle Scholar
Alper, J. (2003) Biotech thinking comes to academic medical centres. Science 299, 1303–5CrossRefGoogle Scholar
Goeddel, D. V., and Levinson, A. D. (2000) Robert A. Swanson (1947–99). Nature 403, 264CrossRefGoogle Scholar
Hall, S., (1988) Invisible frontiers. Atlantic
Vajo, Z., Fawcett, J., and Duckworth, W. C. (2001) Recombinant DNA technology in the treatment of diabetes: Insulin analogs. Endocr. Rev. 22, 706–17CrossRefGoogle ScholarPubMed
Barinaga, M. (2000) Asilomar revisited: Lessons for today? Science 287, 1584–5CrossRefGoogle ScholarPubMed
Kornberg, A. (1995) The golden helix: Inside biotech ventures. University Science Books
Dalton, R., and Schiermeier, Q. (1999) Genentech pays $200m over growth hormone ‘theft’. Nature 402, 335CrossRefGoogle Scholar
Maeder, T. (2003) The orphan drug backlash. Sci. Am. 288, 70–7CrossRefGoogle ScholarPubMed
Lahteenmaki, R., and Fletcher, L. (2002) Public biotechnology 2001 – the numbers. Nat. Biotechnol. 20, 551–5CrossRefGoogle ScholarPubMed
Agres, T. (2003) Licenses worth a billion. The Scientist 17, 55Google Scholar
Ziomek, C., (1998) Commercialisation of proteins produced in the mammary gland. Theriogeniology 49, 139CrossRefGoogle Scholar
Steinberg, F. M., and Raso, J. (1998) Biotech pharmaceuticals and biotherapy: An overview. J. Pharm. Pharm. Sci. 1, 48–59Google ScholarPubMed
Ezzell, C. (2001) Magic bullets fly again. Sci. Am. 285, 34–41CrossRefGoogle Scholar
Stevens, D. L.. (1996) Group A streptococcal bacteremia: The role of tumor necrosis factor in shock and organ failure. J. Infect. Dis. 173, 619–26CrossRefGoogle Scholar
Inoue, N., Takeuchi, M., Ohashi, H., and Suzuki, T. (1995) The production of recombinant human erythropoietin. Biotechnol. Annu. Rev. 1, 297–313CrossRefGoogle ScholarPubMed
Pfeffer, L.. (1998) Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58, 2489–99Google ScholarPubMed
Gutterman, J. (1994) Cytokine therapeutics: Lessons from interferon alpha. Proc. Nat'l. Acad. Sci. 91, 1198–1205CrossRefGoogle ScholarPubMed
Brown, J. B. (1986) Gonadotrophins. In Infertility: Male and Female, ed. V. Insier and B. Lunenfield. Churchill Livingston, pp. 000–000
Laffan, M., and Tuddenham, E. (1998) Science, medicine, and the future: Assessing thrombotic risk. BMJ 317, 520–3CrossRefGoogle ScholarPubMed
DeFrancesco, L. (2001) First sepsis drug nears market. Nature 7, 516–17Google ScholarPubMed
Lu, Y.. (2001) Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation 104, 594–9CrossRefGoogle ScholarPubMed
Griffioen, A. W., and Molema, G. (2000) Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52, 237–68Google ScholarPubMed
Li, R. H., and Wozney, J. M. (2001) Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol. 19, 255–65CrossRefGoogle ScholarPubMed
Teitelbaum, S. L., and Ross, F. P. (2003) Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638–49CrossRefGoogle ScholarPubMed
Chiurel, M. (2000) Whatever happened to leptin. Nature 404, 538–40CrossRefGoogle Scholar
Mattson, M. P. (2001) Lose weight STAT: CNTF tops leptin. TINS 24, 313–14Google ScholarPubMed
Tomalin, C. (2002) Samuel Pepys: The unequalled self. Penguin Viking
Hess, J., and Schmidt, P. (1984) The first blood banker: Oswald Hope Robertson. Transfusion 24, 404–7Google Scholar
Obituary. (2000) Rene Favaloro. The Times (London), July 31
Green, H. (1991) Cultured cells for the treatment of disease. Sci. Am. 265, 96–102CrossRefGoogle Scholar
Petit-Zeman, S. (2001) Regenerative medicine. Nature Biotechnology 19, 201–6CrossRefGoogle ScholarPubMed
Rodan, G. M., TJ. (2000) Therapeutic approaches to bone diseases. Science 289, 1508CrossRefGoogle ScholarPubMed
Lindahl, A., Brittberg, M., and Peterson, L. (2003) Cartilage repair with chondrocytes: Clinical and cellular aspects. Novartis Found. Symp. 249, 175–86Google ScholarPubMed
Oberpenning, F., Meng, J., Yoo, J. J., and Atala, A. (1999) De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat. Biotechnol. 17, 149–55CrossRefGoogle ScholarPubMed
Griffith, L. G., and Naughton, G. (2002) Tissue engineering – current challenges and expanding opportunities. Science 295, 1009–14CrossRefGoogle ScholarPubMed
Dynes, M. (2003) Heart transplant secret of the hospital gardiner. The Times (London), April 26
Dyer, C. (1999) English teenager given heart transplant against her will. BMJ 319, 209CrossRefGoogle ScholarPubMed
Mayes, T. (2003) Ailing tycoon buys Pakistan girl's kidney. The Sunday Times (London), March 23
Mufson, S. (2001) Chinese doctor tells of organ removals after executions. Washington Post, June 27, p. A1
Platt, J. L. (2000) Xenotransplantation: New risks, new gains. Nature 407, 27, 29–30CrossRefGoogle ScholarPubMed
Buhler, L.. (2001) Transplantation of islets of Langerhans: New developments. Swiss Med. Wkly. 131, 671–80Google Scholar
Lumelsky, N.. (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389–94CrossRefGoogle ScholarPubMed
Good, R. A., Gatti, R. A., Hong, R., and Meuwissen, H. J. (1969) Graft treatment of immunological deficiency. Lancet 1, 1162Google ScholarPubMed
Good, R. (1971) Immunodeficiency in developmental perspective. The Harvey Lectures, series 67, 1–107
Parkman, R. (1986) The application of bone marrow transplantation to the treatment of genetic diseases. Science 232, 1373–8CrossRefGoogle ScholarPubMed
Gluckman, E.. (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321, 1174–8CrossRefGoogle Scholar
Barinaga, M. (2000) Fetal neuron grafts pave the way for stem cell therapies. Science 287, 1421–2CrossRefGoogle ScholarPubMed
Li, Y., Field, P., and Raisman, G. (1997) Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 277, 2000–2CrossRefGoogle ScholarPubMed
Thomson, J. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–7CrossRefGoogle ScholarPubMed
Marshall, E. (2000) The business of stem cells. Science 287, 1419–21CrossRefGoogle ScholarPubMed
Aldous, P. (2001) Can they rebuild this? Nature 410, 622–5CrossRefGoogle Scholar
Manouvrier-Hanu, S., Holder-Espinasse, M., and Lyonnet, S. (1999) Genetics of limb anomalies in humans. TIGS 15, 409–17CrossRefGoogle ScholarPubMed
Eldadah, Z. A.. (2001) Familial tetralogy of fallot caused by mutation in the jagged gene. Hum. Mol. Genet. 10, 163–9CrossRefGoogle Scholar
Rosner, F. (1969) Hemophilia in the Talmud and rabbinic writings. Ann. Intern. Med. 70, 833–7CrossRefGoogle ScholarPubMed
Roth, E. F., Raventos-Suarez, C., Rinaldi, A., and Nagel, R. L. (1983) Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 80, 298–9CrossRefGoogle ScholarPubMed
Chakravarti, A., and Chakraborty, R. (1978) Elevated frequency of Tay-Sachs disease among Ashkenazic Jews unlikely by genetic drift alone. Am. J. Hum. Genet. 30, 256–61Google ScholarPubMed
Hogenauer, C.. (2000) Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: An evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am. J. Hum. Genet. 67, 1422–7CrossRefGoogle ScholarPubMed
Kuper, A. (2003) Incest, cousin marriage, and the origin of the human sciences in the nineteenth century. Past and Present Society 174, 155–83Google Scholar
Gibbons, A. (1993) The risks of inbreeding. Science 259, 1252CrossRefGoogle ScholarPubMed
Cao, A., and Rosatelli, M. C. (1993) Screening and prenatal diagnosis of the haemoglobinopathies. Baillieres Clin. Haematol. 6, 263–86CrossRefGoogle ScholarPubMed
Modell, B., and Darr, A. (2002) Genetic counselling and customary consanguineous marriage. Nature, Genetics 3, 225–9CrossRefGoogle ScholarPubMed
Kaback, M. M. (2001) Screening and prevention in Tay-Sachs disease: Origins, update, and impact. Adv. Genet. 44, 253–65Google ScholarPubMed
Ekstein, J., and Katzenstein, H. (2001) The Dor Yeshorim story: Community-based carrier screening for Tay-Sachs disease. Adv. Genet. 44, 297–310Google ScholarPubMed
Handyside, A. H., Kontogianni, E. H., Hardy, K., and Winston, R. M. (1990) Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 344, 768–70CrossRefGoogle ScholarPubMed
Rifkin, J., (1998) The biotech century. Victor Gollanz
Editorial. (1994) China's misconception of eugenics. Nature 367, 3
Kumar, S. (2003) Ratio of girls to boys in India continues to decline. BMJ 327, 1007CrossRefGoogle Scholar
Crockin, S. (2001) Adam Nash: Legally speaking, a happy ending or slippery slope? Reprod. Biomed. Online 2, 6–7CrossRefGoogle ScholarPubMed
Levy, N. (2002) Deafness, culture and choice. J. Med. Ethics 28, 284–5CrossRefGoogle Scholar
Shakespeare, T. (2003) How perfect do we want our babies to be?, The Sunday Times (London), November 23
Dyer, C. (2000) Appeal court bars sterilisation of woman with learning disabilities. The Guardian, May 19
Papadopoulos, G. K., Wijmenga, C., and Koning, F. (2001) Interplay between genetics and the environment in the development of celiac disease: Perspectives for a healthy life. J. Clin. Invest. 108, 1261–6CrossRefGoogle ScholarPubMed
Cohen, F. E. and Kelly, J. W. (2003) Therapeutic approaches to protein misfolding diseases. Nature 426, 405–9CrossRefGoogle ScholarPubMed
Anderson, W. F. (1992) Human gene therapy. Science 256, 808–13CrossRefGoogle ScholarPubMed
Williams, D., and Baum, C. (2003) Medicine: Gene therapy – new challenges ahead. Science 302, 400–1CrossRefGoogle ScholarPubMed
Ferber, D. (2001) Gene therapy: Safer and virus-free? Science 294, 1638–42CrossRefGoogle ScholarPubMed
Stock, G., and Campbell, J., (2000) Engineering the human germline: An exploration of the science and ethics of altering the genes we pass to our children. Oxford University Press
Lindee, M. (2003) Watson's world. Science 300, 432–4CrossRefGoogle Scholar
McLaren, A. (1998) Correspondence. Nature 392, 645CrossRefGoogle Scholar
Nielsen, T. (1997) Human germline therapy. McGill Journal of Medicine 3, 126–132Google Scholar
Peltonen, L., and McKusick, V. A. (2001) Genomics and medicine: Dissecting human disease in the postgenomic era. Science 291, 1224–9CrossRefGoogle ScholarPubMed
Evans, W. E., and Relling, M. V. (1999) Pharmacogenomics: Translating functional genomics into rational therapeutics. Science 286, 487–91CrossRefGoogle ScholarPubMed
Wolf, C., Smith, G., and Smith, R. L. (2000) Science, medicine, and the future: Pharmacogenetics. BMJ 320, 987CrossRefGoogle ScholarPubMed
Mossialos, E., and Dixon, A. (2001) Genetic testing and insurance: Opportunities and challenges for society. Trends Mol. Med. 7, 323–4CrossRefGoogle ScholarPubMed
Ridley, M. (1999) Genome: The autobiography of a species in 23 chapters. Fourth Estate
Appleyard, B. (1999) Brave new worlds. HarperCollins
Charatan, F. (2001) US spending on prescription drugs rose by 19% in 2000. BMJ 322, 1198Google Scholar
Gottlieb, S. (2002) Congress criticises drugs industry for misleading advertising. BMJ 325, 1379CrossRefGoogle ScholarPubMed
Binswanger, H. (2003) HIV/AIDS treatment for millions. Science 292, 221CrossRefGoogle Scholar
Cohen, J. (2003) Companies, donor's pledge to close gap in AIDS treatment. Science 289, 368CrossRefGoogle Scholar
Caplan, A. (2004) Is biomedical research too dangerous to pursue? Science 303, 1142CrossRefGoogle Scholar
Harpending, H., and Rogers, A. (2000) Genetic perspectives on human origins and differentiation. Ann. Rev. Genomics Hum. Genet. 1, 361–85CrossRefGoogle Scholar
Haviland, W. (2000) Human evolution and prehistory. Harcourt
Neiburger, E. J. (2000) Dentistry in ancient Mesopotamia. J. Mass. Dent. Soc. 49, 16–19Google ScholarPubMed
Keynes, R. (2002) Annie's Box. Fourth Estate
Coale, A. J. (1974) The history of the human population. Sci. Am. 231, 41CrossRefGoogle ScholarPubMed
Eaton, S. B., and Konner, M. (1985) Palaeolithic nutrition: A consideration of its nature and current implications. N. Engl. J. Med. 312, 283–9CrossRefGoogle Scholar
McClaren, A. (1978) Birth control in nineteenth century England. Croom Helm
Hardy, A. (2001) Health and medicine in Britain since 1860. Palgrave
Riley, J. (2001) Rising life expectancy: a global history. Cambridge University Press
Fisher, D. (1978) The Rockefeller Foundation and the development of scientific medicine in Great Britain. Minerva 16, 20–41CrossRefGoogle ScholarPubMed
Tomes, N. (1998) The gospel of germs: Men, women, and the microbe in American life. Harvard University Press
Miles, A. (1966) The Lister Institute of Preventive Medicine 1891–1966. Nature 212, 559CrossRef
Medawar, P. B. (1963) The MRC fifty years ago and now. Nature 200, 1039–43CrossRefGoogle Scholar
Tuchman, B. (1962) The proud tower. MacMillan
Austoker, J. (1988) A history of the Imperial Cancer Research Fund, 1902–1986. Oxford University Press
Hare, R. (1970) The birth of penicillin. Allen and Unwin
Fosdick, R. (1952) The history of the Rockefeller Foundation. Harper
Corner, G. (1964) A history of the Rockefeller Institute. Rockefeller University Press
Edwards, R., and Steptoe, P. (1980) A matter of life. Hutchinson
Perut, M. F. (1999) Will medicine outgrow support? Nature 399, 299CrossRefGoogle Scholar
Abelson, P. (1968) The advancement of the nation's health. Science 158, 51Google Scholar
Strickland, S. (1971) Integration of medical research and health policies. Science 173, 1093CrossRefGoogle ScholarPubMed
Editorial. (1965) Does the United States have a science policy? Nature 217, 225–31
Kornberg, A. (1987) The NIH did it! Science 278, 1863CrossRefGoogle Scholar
Strauss, S. (2000) www:nccam.nih.gov/ne/testimony/houseoflords.html
Doll, R. (1992) Sir Austin Bradford Hill and the progress of medical science. BMJ 305, 1521CrossRefGoogle Scholar
Obituary. (2003) Louis Lasagna. BMJ 327, 565CrossRef
Lewin, B. (1970) Second golden age of molecular biology. Nature 227, 1009–13CrossRefGoogle ScholarPubMed
Smith, F. B. (1979) The peoples health 1830–1910. Holmes and Meier
Diamond, J. (1998) Guns, Germs, and Steel. Vintage
Shaw, G. B. (1911) Preface to The Doctors Dilemma. Penguin
Rosenberg, D., and Bloom, H. (1990) The Story of J. Faber and Faber
Youngson, A. J. (1979) The scientific revolution in Victorian medicine. Holmes and Meier
Loudon, I. (1992) The transformation of maternal mortality. BMJ 305, 1557CrossRefGoogle ScholarPubMed
Rosenberg, K. R., and Trevathan, W. R. (2001) The evolution of human birth. Sci. Am. 285, 72–7CrossRefGoogle ScholarPubMed
Cohen, J. (1996) Doctor James Young Simpson, Rabbi Abraham de Sola and Genesis Chapter 3, Verse 16. Obstetrics and Gynaecology 88, 895CrossRefGoogle Scholar
Caton, D. (1996) Who said childbirth is natural? The medical mission of Grantly Dick Read. Anaesthesiology 84, 955–64CrossRefGoogle ScholarPubMed
Behague, D. P., Victora, C. G., and Barros, F. C. (2002) Consumer demand for caesarean sections in Brazil. BMJ 324, 942–5CrossRefGoogle Scholar
Short, R. V. (1976) The evolution of human reproduction. Proc. Roy. Soc. B. 195, 3CrossRefGoogle ScholarPubMed
May, R. (1978) Human reproduction reconsidered. Nature 272, 491–5CrossRefGoogle ScholarPubMed
Tanner, J. (1989) Foetus into man: Physical growth from conception to maturity. Castlemead
Short, R. (1984) Breast feeding. Sci. Am. 250, 23CrossRefGoogle ScholarPubMed
Mepham, T. B. (1993) “Humanizing” milk: The formulation of artificial feeds for infants (1850–1910). Med. Hist. 37, 225–49CrossRefGoogle Scholar
Smith, E. (1988) The retreat of tuberculosis, 1850–1950. Croom Helm
Cuthbertson, W. (2000) Evolution of infant nutrition. Brit. J. Nut. 81, 359–371Google Scholar
Forsyth, J.. (2003) Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: Follow up of a randomised controlled trial. BMJ 326, 958–62CrossRefGoogle ScholarPubMed
McNeill, W. (1976) Plagues and peoples. Basil Blackwell
CIA (2002) World Fact Book. www.cia.gov
Langer, W. (1974) Infanticide: A historical survey. Hist. Child. Q. (Winter), 353–66Google ScholarPubMed
Parliament. (1999) House of Commons research paper 99/111. House of Commons
McKeown, T. (1988) The origins of human disease. Basil Blackwell
Halsey, A. (1972) Trends in British society since 1900. Macmillan
Stevenson, J. (1984) British society 1914–45. Penguin
Djerassi, C. (1962) The Pill, pygmy chimps, and Degas' horse. Basic Books
Wardell, D. (1980) Margaret Sanger: Birth control's successful revolutionary. Am. J. Public Health 70, 736–42CrossRefGoogle Scholar
Black, I. (2002) EU replaces cash denied to UN family planning by US. The Guardian, London, July 24
Harris, J. (1992) Clones, genes, and immortality
Editorial. (1968) Ethics and abortion. BMJ 2, 3CrossRef
Paintin, D. (1985) Legal abortion in England and Wales. CIBA Foundation Symposium 115, 4–20Google ScholarPubMed
Ho, P. C. (2000) Emergency contraception: Methods and efficacy. Curr. Opin. Obstet. Gynecol. 12, 175–9CrossRefGoogle ScholarPubMed
Ullman, A. (2000) The development of Mifepristone: A pharmaceutical drama in three acts. Am. Med. Women's Ass. 55 (suppl.) 117–120Google Scholar
Kolata, G. (1978) In vitro fertilization: Is it safe and repeatable? Science 201, 698Google ScholarPubMed
Trounson, A. L. J., Wood, C., Webb, J., and Wood, J. (1981) Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science 212, 681–2CrossRefGoogle ScholarPubMed
Edwards, R., and Steptoe, P. (1983) Current status of in-vitro fertilisation and implantation of human embryos. The Lancet 2, 1265–9CrossRefGoogle ScholarPubMed
Tesarik, J., and Mendoza, C. (1999) In vitro fertilization by intracytoplasmic sperm injection. Bioessays 21, 791–8013.0.CO;2-Z>CrossRefGoogle ScholarPubMed
Powell, K. (2003) Seeds of doubt. Nature 422, 656–8CrossRefGoogle Scholar
Gosden, R. (1999) Designer babies. Phoenix
Porcu, E.. (2000) Clinical experience and applications of oocyte cryopreservation. Mol. Cell. Endocrinol. 169, 33–7CrossRefGoogle ScholarPubMed
Harris, R. (2002) Human babies in germ-line juggernaut. Current Biology 11, R539–40CrossRefGoogle Scholar
Editorial. (1985) Powell bites dust: The British government needs to think hard about surrogacy. Nature 314, 568CrossRef
Stromberg, B.. (2002) Neurological sequelae in children born after in-vitro fertilisation: A population-based study. Lancet 359, 461–5CrossRefGoogle ScholarPubMed
Silver, L. (1998) Remaking Eden: Cloning, genetic engineering and the future of humankind? Phoenix
McCarty, M. (1985) The transforming principle. Norton
Judson, T. (1979) The eighth day of creation. Jonathan Cape
Olby, R. (2003) Quiet debut of the double helix. Nature 421, 402–5CrossRefGoogle ScholarPubMed
Crick, F. (1993) Looking backwards: A birthday card for the double helix. Gene 135, 15–18CrossRefGoogle ScholarPubMed
Griffith, J. S. (1967) Self-replication and scrapie. Nature 215, 1043–4CrossRefGoogle ScholarPubMed
Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. USA 95, 13363–83CrossRefGoogle ScholarPubMed
Melov, S.. (1999) Mitochondrial DNA rearrangements in ageing human brain and in situ PCR of mtDNA. Neurology. Ageing 20, 565–71CrossRefGoogle ScholarPubMed
Wallace, D. C. (1997) Mitochondrial DNA in ageing and disease. Sci. Am. 277, 40–7CrossRefGoogle ScholarPubMed
Gemmell, N. J., and Sin, F. Y. (2002) Mitochondrial mutations may drive Y chromosome evolution. Bioessays 24, 275–9CrossRefGoogle ScholarPubMed
Ponamarev, M. V.. (2002) Active site mutation in DNA polymerase gamma associated with progressive external ophthalmoplegia causes error-prone DNA synthesis. J. Biol. Chem. 277, 15225–8CrossRefGoogle ScholarPubMed
Melton, L. (2000) Womb wars. Sci. Am. 283, 24, 26CrossRefGoogle ScholarPubMed
Yu, N.. (2002) Disputed maternity leading to identification of tetragametic chimerismN. Engl. J. Med. 346, 1545–52CrossRefGoogle ScholarPubMed
Monod, J. (1972) Chance and Necessity. Collins
Crow, J. F. (1997) The high spontaneous mutation rate: Is it a health risk? Proc. Natl. Acad. Sci. USA 94, 8380–6CrossRefGoogle ScholarPubMed
Friedberg, E. C. (2001) How nucleotide excision repair protects against cancer. Nature Rev. Cancer 1, 22–33CrossRefGoogle ScholarPubMed
Bartek, J., and Lukas, J. (2003) Damage alert. Nature 421, 486–7CrossRefGoogle ScholarPubMed
Crow, J. F. (2000) The origins, patterns and implications of human spontaneous mutation. Nat. Rev. Genet. 1, 40–7CrossRefGoogle ScholarPubMed
Deininger, P. L., and Batzer, M. A. (1999) Alu repeats and human disease. Mol. Genet. Metab. 67, 183–93CrossRefGoogle ScholarPubMed
Li, X.. (2001) Frequency of recent retrotransposition events in the human factor IX gene. Hum. Mutat. 17, 511–19CrossRefGoogle ScholarPubMed
International Human Genome Sequencing Consortium. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860–921CrossRef
Greaves, M. (2002) Childhood leukaemia. BMJ 324, 283–7CrossRefGoogle ScholarPubMed
Nekrutenko, A., and Li, W. H. (2001) Transposable elements are found in a large number of human protein-coding genes. Trends Genet. 17, 619–21CrossRefGoogle Scholar
Smit, A. F. (1999) Interspersed repeats and other mementoes of transposable elements in mammalian genomes. Curr. Opin. Genet. Dev. 9, 657–63CrossRefGoogle Scholar
Symer, D. (2002) Human L1 retrotransposition is associated with genetic instability in vivo. Cell 110, 327–8CrossRefGoogle ScholarPubMed
Hughes, V. M., and Datta, N. (1983) Conjugative plasmids in bacteria of the ‘pre-antibiotic’ era. Nature 302, 725–6CrossRefGoogle ScholarPubMed
Karaolis, D. K., Lan, R., Kaper, J. B., and Reeves, P. R. (2001) Comparison of Vibrio cholerae pathogenicity islands in sixth and seventh pandemic strains. Infect. Immun. 69, 1947–52CrossRefGoogle ScholarPubMed
Stephens, C. and Murray, W. (2001) Pathogen evolution: How good bacteria go bad, Curr Biol 11, R53–6CrossRefGoogle ScholarPubMed
Groisman, E. A., and Ochman, H. (1997) How Salmonella became a pathogen. Trends Microbiol. 5, 343–9CrossRefGoogle ScholarPubMed
Herskind, A. M.. (1996) The heritability of human longevity: A population-based study of 2872 Danish twin pairs born 1870–1900. Hum. Genet. 97, 319–23CrossRefGoogle ScholarPubMed
Iachine, I. A.. (1998) How heritable is individual susceptibility to death? The results of an analysis of survival data on Danish, Swedish and Finnish twins. Twin Res. 1, 196–205CrossRefGoogle ScholarPubMed
Lichtenstein, P.. (2000) Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78–85CrossRefGoogle Scholar
Weatherall, D. (1991) The new genetics and clinical practice. Oxford University Press
Marx, J. (2002) Unravelling the cause of diabetes. Science 296, 686–9CrossRefGoogle Scholar
Cole, T. J. (2000) Secular trends in growth. Proc. Nutr. Soc. 59, 317–24CrossRefGoogle ScholarPubMed
Brundtland, G. H., Liestol, K., and Walloe, L. (1980) Height, weight and menarcheal age of Oslo schoolchildren during the last 60 years. Ann. Hum. Biol. 7, 307–22CrossRefGoogle ScholarPubMed
Floud, R., Wachter, K., and Gregory, A. (1990) Height, health and history. Cambridge University Press
Wilmoth, J. R., Deegan, L. J., Lundstrom, H., and Horiuchi, S. (2000) Increase of maximum life-span in Sweden, 1861–1999. Science 289, 2366–8CrossRefGoogle Scholar
Alberts, B., et al., (2002) The molecular biology of the cell. Garland
Ridley, M. (2003) Nature via nurture. Fourth Estate
Porter, R. (1997) The greatest benefit to mankind. Oxford University Press
Masutomi, K.. (2003) Telomerase maintains telomere structure in normal human cells. Cell 114, 241–53CrossRefGoogle ScholarPubMed
Wong, J. M., and Collins, K. (2003) Telomere maintenance and disease. Lancet 362, 983–8CrossRefGoogle ScholarPubMed
Cohen, M., Lee, K. K., Wilson, K. L., and Gruenbaum, Y. (2001) Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. Trends Biochem. Sci. 26, 41–7CrossRefGoogle ScholarPubMed
Yaffe, M. (1999) The machinery of mitochondrial inheritance and behaviour. Science 283, 1493–7CrossRefGoogle Scholar
Wallace, D. C. (1999) Mitochondrial diseases in man and mouse. Science 283, 1482–8CrossRefGoogle Scholar
Marchington, D. R.. (1998) Evidence from human oocytes for a genetic bottleneck in an mtDNA disease. Am. J. Hum. Genet. 63, 769–75CrossRefGoogle Scholar
Larson, J. E., and Cohen, J. C. (2000) Cystic fibrosis revisited. Mol. Genet. Metab. 71, 470–7CrossRefGoogle ScholarPubMed
McNeil, P., Miyake, K., and Vogel, S. (2003) The endomembrane requirement for cell surface repair. PNAS 100, 4592–7CrossRefGoogle ScholarPubMed
Brady, S. T. (1993) Motor neurons and neurofilaments in sickness and in health. Cell 73, 1–3CrossRefGoogle ScholarPubMed
Winchester, B., Vellodi, A., and Young, E. (2000) The molecular basis of lysosomal storage diseases and their treatment. Biochem. Soc. Trans. 28, 150–4CrossRefGoogle ScholarPubMed
Keller, J., Gee, J., and Ding, Q. (2002) The proteasome in brain ageing. Ageing Res. Rev. 1, 279–93CrossRefGoogle Scholar
Wilmut, I.. (1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810–13CrossRefGoogle ScholarPubMed
Levi-Montalcini, R. (1987) The nerve growth factor 35 years later. Science 237, 1154–62CrossRefGoogle ScholarPubMed
Jacobson, M. D., Weil, M., and Raff, M. C. (1997) Programmed cell death in animal development. Cell 88, 347–54CrossRefGoogle ScholarPubMed
Raff, M. C. (1992) Social controls on cell survival and cell death. Nature 356, 397–400CrossRefGoogle ScholarPubMed
Krammer, P. H. (2000) CD95's deadly mission in the immune system. Nature 407, 789–95CrossRefGoogle ScholarPubMed
Hetts, S. W. (1998) To die or not to die: An overview of apoptosis and its role in disease. JAMA 279, 300–7CrossRefGoogle ScholarPubMed
Fleisher, T. A., Straus, S. E., and Bleesing, J. J. (2001) A genetic disorder of lymphocyte apoptosis involving the fas pathway: The autoimmune lymphoproliferative syndrome. Curr. Allergy Asthma Rep. 1, 534–40CrossRefGoogle ScholarPubMed
Niederkorn, J. Y. (1999) The immune privilege of corneal allografts. Transplantation 67, 1503–8CrossRefGoogle ScholarPubMed
Uckan, D.. (1997) Trophoblasts express Fas ligand: A proposed mechanism for immune privilege in placenta and maternal invasion. Mol. Hum. Reprod. 3, 655–62CrossRefGoogle ScholarPubMed
Brash, D. (1996) Cellular proofreading. Nature Medicine 2, 525–6CrossRefGoogle ScholarPubMed
Fadeel, B., Orrenius, S., and Zhivotovsky, B. (1999) Apoptosis in human disease: A new skin for the old ceremony? Biochem. Biophys. Res. Commun. 266, 699–717CrossRefGoogle ScholarPubMed
Levine, A. (1997) p53 the cellular gatekeeper for growth and division. Cell 88, 323–31CrossRefGoogle ScholarPubMed
Hayflick, L. (1994) How and why we age. Ballantine Books
Ferri, K. F., and Kroemer, G. (2001) Mitochondria – the suicide organelles. Bioessays 23, 111–153.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Fuchs, E. (1997) Of mice and men: Genetic disorders of the cytoskeleton (Keith R. Porter Lecture, 1996). Mol. Biol. Cell 8, 189–203CrossRefGoogle Scholar
Nicklas, R. B. (1997) How cells get the right chromosomes. Science 275, 632–7CrossRefGoogle ScholarPubMed
Dynes, M. (2003) Miracle birth of the elusive baby found growing on mother's liver. The Times, May 24
Nilsson, L. (1990) A child is born. Dell
Brent, L., and Owen, R. (1996) A history of transplantation immunology. Academic Press
Barinaga, M. (2002) Cells exchanged during pregnancy live on. Science 296, 2169–72CrossRefGoogle Scholar
Barker, D. (1998) Mothers, babies and health in later life. Churchill Livingston
Wolpert, L. (1991) The triumph of the embryo. Oxford University Press
Qumsiyeh, M. B., Kim, K. R., Ahmed, M. N., and Bradford, W. (2000) Cytogenetics and mechanisms of spontaneous abortions: Increased apoptosis and decreased cell proliferation in chromosomally abnormal villi. Cytogenet. Cell Genet. 88, 230–5CrossRefGoogle ScholarPubMed
Griffin, D. K. (1996) The incidence, origin, and etiology of aneuploidy. Int. Rev. Cytol. 167, 263–96CrossRefGoogle ScholarPubMed
Norimura, T.. (1996) p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat. Med. 2, 577–80CrossRefGoogle ScholarPubMed
Heyer, B. S., MacAuley, A., Behrendtsen, O., and Werb, Z. (2000) Hypersensitivity to DNA damage leads to increased apoptosis during early mouse development. Genes Dev. 14, 2072–84Google ScholarPubMed
Stewart, R. J., Sheppard, H., Preece, R., and Waterlow, J. C. (1980) The effect of rehabilitation at different stages of development of rats marginally malnourished for ten to twelve generations. Br. J. Nutr. 43, 403–12CrossRefGoogle ScholarPubMed
Gluckman, P. D. (2001) Editorial: Nutrition, glucocorticoids, birth size, and adult disease. Endocrinology 142, 1689–91CrossRefGoogle ScholarPubMed
Lumbers, E. R., Yu, Z. Y., and Gibson, K. J. (2001) The selfish brain and the Barker hypothesis. Clin. Exp. Pharmacol. Physiol. 28, 942–7CrossRefGoogle ScholarPubMed
Garofano, A., Czernichow, P., and Breant, B. (1997) In utero undernutrition impairs rat beta-cell development. Diabetologia 40, 1231–4CrossRefGoogle ScholarPubMed
Kwong, W. Y.. (2000) Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development 127, 4195–202Google ScholarPubMed
Butterworth, C. E. Jr., and Bendich, A. (1996) Folic acid and the prevention of birth defects. Ann. Rev. Nutr. 16, 73–97CrossRefGoogle ScholarPubMed
Biever, C. (2003) Bring me sunshine. The New Scientist 179, 30–1Google Scholar
van der Meulen, J., et al. (1999) Fetal programming associated with the Dutch famine 1944–5. In Fetal Programming: Influences on Development and Disease in Later Life, ed. P. O'Brien, T. Wheeler, and D. J. P. Barker. Royal College of Obstetricians and Gynaecologists, pp. 45–56
Stein, Z., Susser, M., Saenger, G., and Marolla, F. (1975) Famine and human development: The Dutch hunger winter of 1944–1945. Oxford University Press
Boyd-Orr, J. (1936) Food, health and income. Macmillan
Eriksson, J.. (1999) Catch-up growth in childhood and death from coronary heart disease: Longitudinal study. BMJ 318, 427–31CrossRefGoogle ScholarPubMed
Trowell, H., and Burkitt, D. (1981) Western diseases, their emergence and prevention. Harvard University Press
Diamond, J. (2003) The double puzzle of diabetes. Nature 423, 599–602CrossRefGoogle ScholarPubMed
Prentice, A. (2003) Intrauterine factors, adiposity and hyperinsulinaemia. BMJ 327, 880–1CrossRefGoogle ScholarPubMed
Porter, D. (1999) Health, civilisation and the state. Routledge
Le Fanu, J. (1999) The rise and fall of modern medicine. Little, Brown
Osmond, C., and Barker, D. J. (2000) Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ. Health. Perspect. 108 (suppl. 3) 545–53CrossRefGoogle ScholarPubMed
Chandra, R. K. (1991) Interactions between early nutrition and the immune system. Ciba. Found. Symp. 156, 77–89Google ScholarPubMed
Moore, S. E.. (1997) Season of birth predicts mortality in rural Gambia. Nature 388, 434CrossRefGoogle ScholarPubMed
Stephens, T., and Brynner, R. (2001) Dark remedy: The impact of thalidomide and its revival as a vital medicine. Perseus
Colborn, T., Dumanoski, D., and Myers, J. (1997) Our stolen future. Abacus
Ibarreta, D. and Swan, S. (2002) The DES story: Long term consequences of prenatal exposure. In The Precautionary Principle in the 20th Century: Late Lessons from Early Warnings, ed. Poul Harremoës et al. European Environment Agency, pp. 90–9
Kaiser, J. (2000) Endocrine disrupters: Panel cautiously confirms low-dose effects. Science 290, 695–7CrossRefGoogle ScholarPubMed
Hunt, P. A.. (2003) Bisphenol exposure causes meiotic aneuploidy in the female mouse. Curr. Biol. 13, 546–53CrossRefGoogle ScholarPubMed
Rennie, J. (1996) Perinatal management of the lower margin of viability. Arch. Dis. Child 74, F214–F218CrossRefGoogle ScholarPubMed
Christie, B. (2000) Premature babies have high death and disability rate. BMJ 321, 467CrossRefGoogle ScholarPubMed
Wickelgren, I. (2004) Resetting pregnancy's clock. Science 304, 666–8CrossRefGoogle ScholarPubMed
Tin, W., Wariyar, U., and Hey, E. (1997) Changing prognosis for babies of less than 28 weeks' gestation in the north of England between 1983 and 1994. BMJ 314, 107–11CrossRefGoogle ScholarPubMed
Avery, M. E. (2000) Surfactant deficiency in hyaline membrane disease: The story of discovery. Am. J. Respir. Crit. Care Med. 161, 1074–5CrossRefGoogle Scholar
Uauy, R., and Hoffman, D. (2003) Essential fat requirements of preterm infants., Am. J. Clin. Nutr. 71, 245–50CrossRefGoogle Scholar
Field, T. (1988) Stimulation of preterm infants. Pediatr. Rev. 10, 149–53CrossRefGoogle ScholarPubMed
Schanberg, S. M., and Field, T. M. (1987) Sensory deprivation stress and supplemental stimulation in the rat pup and preterm human neonate. Child Dev. 58, 1431–47CrossRefGoogle ScholarPubMed
Hack, M., and Merkatz, I. R. (1995) Preterm delivery and low birth weight – a dire legacy. N. Engl. J. Med. 333, 1772–4CrossRefGoogle ScholarPubMed
Liu, Y., Albertsson-Wikland, K., and Karlberg, J. (2000) Long-term consequences of early linear growth retardation (stunting) in Swedish children. Pediatr. Res. 47, 475–80CrossRefGoogle Scholar
Karlberg, J., and Luo, Z. C. (2000) Foetal size to final height. Acta Paediatr. 89, 632–6CrossRefGoogle ScholarPubMed
Bogin, B. (1999) Patterns of human growth. Cambridge University Press
Janeway, C. A. Jr. (2001) How the immune system works to protect the host from infection: A personal view. Proc. Natl. Acad. Sci. USA 98, 7461–8CrossRefGoogle ScholarPubMed
Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415, 389–95CrossRefGoogle ScholarPubMed
Carswell, E. A.. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666–70CrossRefGoogle ScholarPubMed
McCormick, J. K., Yarwood, J. M., and Schlievert, P. M. (2001) Toxic shock syndrome and bacterial superantigens: An update. Ann. Rev. Microbiol. 55, 77–104CrossRefGoogle ScholarPubMed
Libby, P. (2002) Atherosclerosis: The new view. Sci. Am. 286, 46–55CrossRefGoogle ScholarPubMed
Yazdanbakhsh, M., Kremsner, P. G., and Ree, R. (2002) Allergy, parasites, and the hygiene hypothesis. Science 296, 490–4CrossRefGoogle ScholarPubMed
Martinez, F. D., and Holt, P. G. (1999) Role of microbial burden in aetiology of allergy and asthma. Lancet 354 (suppl. 2). SII12–15CrossRefGoogle ScholarPubMed
Mackay, I. R. (2000) Tolerance and autoimmunity. BMJ 321, 93–6CrossRefGoogle ScholarPubMed
Goldbach-Mansky, R., and Lipsky, P. E. (2003) New concepts in the treatment of rheumatoid arthritis. Ann. Rev. Med. 54, 197–216CrossRefGoogle ScholarPubMed
Todd, J. A. (2001) Human genetics: Tackling common disease. Nature 411, 537, 539CrossRefGoogle ScholarPubMed
Ye, X.. (2000) Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science 287, 303–5CrossRefGoogle ScholarPubMed
Rajakumar, K. (2000) Pellagra in the United States: A historical perspective. South. Med. J. 93, 272–7CrossRefGoogle ScholarPubMed
Chan, A. C. (1998) Vitamin E and atherosclerosis. J. Nutr. 128, 1593–6CrossRefGoogle ScholarPubMed
Bang, H. O., and Dyerberg, J. (1981) Personal reflections on the incidence of ischaemic heart disease in Oslo during the Second World War. Acta. Med. Scand. 210, 245–8CrossRefGoogle ScholarPubMed
Connor, W. E. (2000) Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 71, 171S–5SCrossRefGoogle ScholarPubMed
Lamartiniere, C. A. (2000) Protection against breast cancer with genistein: A component of soy. Am. J. Clin. Nutr. 71, 1705S–7S; discussion 1708S–9SCrossRefGoogle ScholarPubMed
Taubes, G. (2001) Nutrition: The soft science of dietary fat. Science 291, 2536–45CrossRefGoogle ScholarPubMed
Fahey, J. W., Zhang, Y., and Talalay, P. (1997) Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. USA 94, 10367–72CrossRefGoogle ScholarPubMed
Brosens, J., and Parker, M. (2003) Oestrogen receptor hikacked. Nature 423, 487–8CrossRefGoogle Scholar
Kogevinas, M. (2001) Human health effects of dioxins: Cancer, reproductive and endocrine system effects. Hum. Reprod. Update 7, 331–9CrossRefGoogle ScholarPubMed
Ames, B., Magaw, R., and Gold, L. (1987) Ranking possible carcinogenic hazards. Science 236, 271–280CrossRefGoogle ScholarPubMed
Janeway, C., Travers, P., Walport, M., and Shlomchik, M. (2001) Immunobiology. Garland Publishing
Tuljapurkar, S., Li, N., and Boe, C. (2000) A universal pattern of mortality decline in the G7 countries. Nature 405, 789–92CrossRefGoogle ScholarPubMed
Kirkwood, T. B., and Austad, S. N. (2000) Why do we age? Nature 408, 233–8CrossRefGoogle ScholarPubMed
Holliday, R. (1995) Understanding ageing. Cambridge University Press
Hayflick, L. (2000) The future of ageing. Nature 408, 267–9CrossRefGoogle ScholarPubMed
Davey, B., Halliday, T., and Hirst, M. (2001) Human biology and health: An evolutionary approach. Open University
Harman, D. (1956) Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 1956 11, 298–300CrossRefGoogle ScholarPubMed
Beckman, K. B., and Ames, B. N. (1998) The free radical theory of aging matures. Physiol. Rev. 78, 547–81CrossRefGoogle ScholarPubMed
Melov, S.. (2000) Extension of life-span with superoxide dismutase/catalase mimetics. Science 289, 1567–9CrossRefGoogle ScholarPubMed
McKenzie, D.. (2002) Mitochondrial DNA deletion mutations: A causal role in sarcopenia. Eur. J. Biochem. 269, 2010–15CrossRefGoogle ScholarPubMed
Brunk, U. T., and Terman, A. (2002) The mitochondrial-lysosomal axis theory of aging: Accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur. J. Biochem. 269, 1996–2002CrossRefGoogle ScholarPubMed
Suter, M.. (2000) Age-related macular degeneration: The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J. Biol. Chem. 275, 39625–30CrossRefGoogle ScholarPubMed
Dirks, A. and Leeuwenburgh, C. (2002) Apoptosis in skeletal muscle with aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R519–27CrossRefGoogle ScholarPubMed
Lamberts, S. W., Beld, A. W., and Lely, A. J. (1997) The endocrinology of aging. Science 278, 419–24CrossRefGoogle Scholar
Rudman, D.. (1990) Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323, 1–6CrossRefGoogle ScholarPubMed
Laron, Z. (2002) Effects of growth hormone and insulin-like growth factor 1 deficiency on ageing and longevity. Novartis Found. Symp. 242, 125–37; discussion 137–42Google ScholarPubMed
Yen, S. S. (2001) Dehydroepiandrosterone sulfate and longevity: New clues for an old friend. Proc. Natl. Acad. Sci. USA 98, 8167–9CrossRefGoogle ScholarPubMed
Lane, M. A., Ingram, D. K., Ball, S. S., and Roth, G. S. (1997) Dehydroepiandrosterone sulfate: A biomarker of primate aging slowed by calorie restriction. J. Clin. Endocrinol. Metab. 82, 2093–6CrossRefGoogle ScholarPubMed
Lord, J. M.. (2001) Neutrophil ageing and immunesenescence. Mech. Ageing Dev. 122, 1521–35CrossRefGoogle ScholarPubMed
Finkel, T., and Holbrook, N. J. (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408, 239–47CrossRefGoogle ScholarPubMed
Finch, C. E., and Tanzi, R. E. (1997) Genetics of aging. Science 278, 407–11CrossRefGoogle ScholarPubMed
Perls, T. T. (1995) The oldest old. Sci. Am. 272, 70–5CrossRefGoogle ScholarPubMed
Martin, G. M., and Oshima, J. (2000) Lessons from human progeroid syndromes. Nature 408, 263–6CrossRefGoogle ScholarPubMed
Hsin, H., and Kenyon, C. (1999) Signals from the reproductive system regulate the lifespan of C. elegans. Nature 399, 362–6CrossRefGoogle ScholarPubMed
Hamilton, M. L.. (2001) Does oxidative damage to DNA increase with age? Proc. Natl. Acad. Sci. USA 98, 10469–74CrossRefGoogle ScholarPubMed
Kayo, T., Allison, D. B., Weindruch, R., and Prolla, T. A. (2001) Influences of aging and caloric restriction on the transcriptional profile of skeletal muscle from rhesus monkeys. Proc. Natl. Acad. Sci. USA 98, 5093–8CrossRefGoogle ScholarPubMed
Cristofalo, V. J.. (1998) Relationship between donor age and the replicative lifespan of human cells in culture: A reevaluation, Proc. Natl. Acad. Sci. USA 95, 10614–9CrossRefGoogle Scholar
Faragher, R. G., and Kipling, D. (1998) How might replicative senescence contribute to human ageing? Bioessays 20, 985–913.0.CO;2-A>CrossRefGoogle ScholarPubMed
Kassem, M.. (1997) Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts. Osteoporosis Int. 7, 514–24CrossRefGoogle ScholarPubMed
Hayflick, L. (2002) DNA replication and traintracks. Science 296, 1611–12CrossRefGoogle ScholarPubMed
Zglinicki, T. (2001) Telomeres and replicative senescence: Is it only length that counts? Cancer Lett. 168, 111–16CrossRefGoogle Scholar
Shay, J. W., and Wright, W. E. (2001) Ageing and cancer: The telomere and telomerase connection. Novartis Found. Symp. 235, 116–25; discussion 125–9, 146–9Google ScholarPubMed
Johnson, F. B., Marciniak, R. A., and Guarente, L. (1998) Telomeres, the nucleolus and aging. Curr. Opin. Cell Biol. 10, 332–8CrossRefGoogle ScholarPubMed
Schwarcz, J. (2001) The genie in the bottle. Freeman
Lock, S. (1983) “O that I were young again”: Yeats and the Steinach operation. Br. Med. J. (Clin. Res. Ed.) 287, 1964–8CrossRefGoogle ScholarPubMed
Alcor Life Extension Foundation. (2000). www.alcor.org
deGrey, A.. (2003) Antiageing technology and pseudoscience. Science 296, 5568–9Google Scholar
Hall, S. (2003) In vivo vitalis? Compounds activate life-extending genes. Science 301, 1165CrossRef
Kirkwood, T. The time of our lives. Weidenfeld and Nicholson
Rettig, R. (1977) Cancer crusade. Princeton University Press
Weisburger, E. K. (1989) Current carcinogen perspectives: De minimis, Delaney and decisions. Sci. Total Environ. 86, 5–13CrossRefGoogle ScholarPubMed
Stehelin, D., Varmus, H. E., Bishop, J. M., and Vogt, P. K. (1976) DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260, 170–3CrossRefGoogle ScholarPubMed
Culliton, B. (1972) Cancer virus theories: Focus of research debate. Science 177, 44–7CrossRefGoogle ScholarPubMed
Peto, J. (2001) Cancer epidemiology in the last century and the next decade. Nature 411, 390–5CrossRefGoogle ScholarPubMed
Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57–70CrossRefGoogle ScholarPubMed
Look, A. (1997) Oncogenic transcription factors in the human acute leukaemias. Science 278, 1059–64CrossRefGoogle Scholar
Marx, J. (2003) Mutant stem cells may seed cancer. Science 301, 1308–10CrossRefGoogle ScholarPubMed
Campisi, J. (2000) Cancer, aging and cellular senescence. In Vivo 14, 183–8Google ScholarPubMed
Artandi, S. E., and DePinho, R. A. (2000) A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev. 10, 39–46CrossRefGoogle ScholarPubMed
Nordstrom, D. K. (2002) Public health. Worldwide occurrences of arsenic in ground water. Science 296, 2143–5CrossRefGoogle ScholarPubMed
Ames, B. N. (1979) Identifying environmental chemicals causing mutations and cancer. Science 204, 587–93CrossRefGoogle ScholarPubMed
Ohshima, H., and Bartsch, H. (1994) Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat. Res. 305, 253–64CrossRefGoogle ScholarPubMed
Iversen, L. (2001) Drugs: A very short introduction. Oxford University Press
Weinberg, R. (1997) Racing to the start of the road: The search for the origin of cancer. Bantam
Peto, R.. (1992) Mortality from tobacco in developed countries: Indirect estimation from national vital statistics. Lancet 339, 1268–78CrossRefGoogle ScholarPubMed
Kmietowicz, Z. (2001) Tobacco company claims that smokers help the economy. BMJ 323, 126CrossRefGoogle ScholarPubMed
Scotto, J., and Bailar, J. (1969) Rigoni-Stern and medical statistics: A nineteenth-century approach to cancer research. J. Hist. Med. Allied Sci. 24, 65–75CrossRefGoogle ScholarPubMed
Pierce, D. A.. (1996) Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950–1990. Radiat. Res. 146, 1–27CrossRefGoogle ScholarPubMed
Obituary. (2002) Dr. Alice Stewart. New York Times
Goldman, M. (1996) Cancer risk of low-level exposure. Science 271, 1821–2CrossRefGoogle ScholarPubMed
Coussens, L. M., and Werb, Z. (2002) Inflammation and cancer. Nature 420, 860–7CrossRefGoogle ScholarPubMed
Gee, D., and M. Greenberg. (2002) Asbestos: From ‘magic’ to malevolent mineral. In The Precautionary Principle in the 20th Century: Late Lessons from Early Warnings, ed. Poul Harremoës et al. European Environment Agency, pp. 49–63
Ferber, D. (2002) Virology: Monkey virus link to cancer grows stronger. Science 296, 1012–15CrossRefGoogle ScholarPubMed
Ames, B. N. (1999) Cancer prevention and diet: Help from single nucleotide polymorphisms. Proc. Natl. Acad. Sci. USA 96, 12216–8CrossRefGoogle ScholarPubMed
Blacklock, C. J.. (2001) Salicylic acid in the serum of subjects not taking aspirin: Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin. J. Clin. Pathol. 54, 553–5CrossRefGoogle Scholar
Doll, R., and Armstrong, B. (1980) Cancer. In Western Diseases, Their Emergence and Prevention, ed. H. Trowell and D. Burkitt. Harvard University Press, pp. 93–112
Leaf, C. (2004) Why we're losing the war on cancer and how to win. Fortune, March 22, 42–9
Drancourt, M., and Raoult, D. (2002) Molecular insights into the history of plague. Microbes Infect. 4, 105–9CrossRefGoogle ScholarPubMed
Halleyday, S. (1999) The great stink of London: Sir Joseph Bazalgette and the cleansing of the Victorian metropolis. Sutton Publishing
Daniel, T. M. (2000) The origins and precolonial epidemiology of tuberculosis in the Americas: Can we figure them out? Int. J. Tuberc. Lung Dis. 4, 395–400Google ScholarPubMed
Baxby, D. (1996) Two hundred years of vaccination. Curr. Biol. 6, 769–72CrossRefGoogle ScholarPubMed
Baker, J. P. (2000) Immunization and the American way: Four childhood vaccines. Am. J. Public Health. 90, 199–207Google Scholar
Vitek, C. R., and Wharton, M. (1998) Diphtheria in the former Soviet Union: Reemergence of a pandemic disease. Emerg. Infect. Dis. 4, 539–50CrossRefGoogle ScholarPubMed
Robertson, S. E.. (1996) Yellow fever: A decade of re-emergence. JAMA 276, 1157–62CrossRefGoogle Scholar
Meldrum, M. (1998) “A calculated risk”: The Salk polio vaccine field trials of 1954. BMJ 317, 1233–6CrossRefGoogle ScholarPubMed
Blume, S., and Geesink, I. (2000) A brief history of polio vaccines. Science 288, 1593–4CrossRefGoogle ScholarPubMed
Nathanson, N., and Fine, P. (2002) Virology: Poliomyelitis eradication–a dangerous endgame. Science 296, 269–70CrossRefGoogle ScholarPubMed
Weiss, R. A. (2001) Animal origins of human infectious disease (Leeuwenhoek Lecture 2001). Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356, 957–77CrossRefGoogle Scholar
Ferber, D. (2002) Public health: Creeping consensus on SV40 and polio vaccine. Science 298, 725–7CrossRefGoogle ScholarPubMed
Behr, M. A. (2001) Comparative genomics of BCG vaccines. Tuberculosis (Edinb.) 81, 165–8CrossRefGoogle ScholarPubMed
Weiner, D. B., and Kennedy, R. C. (1999) Genetic vaccines. Sci. Am. 281, 50–7CrossRefGoogle ScholarPubMed
Madsen, K. M.. (2002) A population-based study of measles, mumps, and rubella vaccination and autism. N. Engl. J. Med. 347, 1477–82CrossRefGoogle ScholarPubMed
Loudon, I. (1987) Puerperal fever, the streptococcus, and the sulphonamides, 1911–1945. BMJ 295, 485–490CrossRefGoogle ScholarPubMed
Levy, S. B. (1998) The challenge of antibiotic resistance. Sci. Am. 278, 46–53CrossRefGoogle ScholarPubMed
Ferber, D. (2003) WHO advises kicking the livestock antibiotic habit. Science 301, 1027CrossRefGoogle ScholarPubMed
Crisostomo, M. I.. (2001) The evolution of methicillin resistance in Staphylococcus aureus: Similarity of genetic backgrounds in historically early methicillin-susceptible and – resistant isolates and contemporary epidemic clones. Proc. Natl. Acad. Sci. USA 98, 9865–70CrossRefGoogle ScholarPubMed
Ferber, D. (2002) Livestock feed ban preserves drug's power. Science 295, 27–8CrossRefGoogle Scholar
Clarke, T. (2003) Drug companies snub antibiotics as pipeline threatens to run dry. Nature 425, 225CrossRefGoogle ScholarPubMed
Reid, S. D.. (2000) Parallel evolution of virulence in pathogenic Escherichia coli. Nature 406, 64–7CrossRefGoogle ScholarPubMed
Eisen, J. A. (2001) Gastrogenomics. Nature 409, 463, 465–6CrossRefGoogle ScholarPubMed
Pupo, G. M., Lan, R., and Reeves, P. R. (2000) Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics. Proc. Natl. Acad. Sci. USA 97, 10567–72CrossRefGoogle ScholarPubMed
Starr, D. (1999) Blood. Warner
Defrancesco, L. (2002) US in grip of West Nile Virus. Nature Medicine 8, 1051CrossRefGoogle ScholarPubMed
Cyranoski, D., and Abbott, A. (2003) Virus detectives seek source of SARS in China's wild animals. Nature 423, 467CrossRefGoogle ScholarPubMed
Balter, M. (2000) Emerging diseases: On the trail of Ebola and Marburg viruses. Science 290, 923–5CrossRefGoogle ScholarPubMed
Berche, P. (2001) The threat of smallpox and bioterrorism. Trends Microbiol. 9, 15–18CrossRefGoogle ScholarPubMed
Cosby, A. (1989) America's forgotten pandemic. Cambridge University Press
Taubenberger, J. K., Reid, A. H., and Fanning, T. G. (2000) The 1918 influenza virus: A killer comes into view. Virology 274, 241–5CrossRefGoogle ScholarPubMed
Webster, R. (2001) A molecular whodunit. Science 293, 1773–5Google ScholarPubMed
Shortridge, K. F. (1999) The 1918 ‘Spanish’ flu: Pearls from swine? Nat. Med. 5, 384–5CrossRefGoogle ScholarPubMed
Kilbourne, E. D. (1997) In pursuit of influenza: Fort Monmouth to Valhalla (and back). Bioessays 19, 641–50CrossRefGoogle Scholar
Pruisner, S., Montaingner, L., and Gallo, R. (2002) Discovering the cause of AIDS. Science 298, 1726–31CrossRefGoogle Scholar
Hillis, D. (2000) Origins of HIV. Science 288, 1757–8CrossRefGoogle ScholarPubMed
Marx, P., Alcabes, P., and Drucker, E. (2001) Serial human passage of simian immunodeficiency virus by unsterile injections and the emergence of epidemic HIV in Africa. Phil. Trans. Roy. Soc. 356, 911–20CrossRefGoogle ScholarPubMed
Hooper, E., (2000) The river: A journey back to the source of HIV and AIDS. Penguin
Weiss, R. A. (2001) Polio vaccines exonerated. Nature 410, 1035–6CrossRefGoogle ScholarPubMed
Richman, D. D. (2001) HIV chemotherapy. Nature 410, 995–1001CrossRefGoogle ScholarPubMed
Weller, I. V., and Williams, I. G. (2001) ABC of AIDS: Antiretroviral drugs. BMJ 322, 1410–12CrossRefGoogle ScholarPubMed
Collinge, J. (1999) Variant Creutzfeldt-Jakob disease. Lancet 354, 317–23CrossRefGoogle ScholarPubMed
Zobeley, E.. (1999) Infectivity of scrapie prions bound to a stainless steel surface. Mol. Med. 5, 240–3Google ScholarPubMed
Sun, M. (1985) Gene-spliced hormone for growth approved. Science 230, 523CrossRefGoogle ScholarPubMed
Ghani, A. C., Ferguson, N. M., Donnelly, C. A., and Anderson, R. M. (2003) Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK. Proc. R. Soc. Lond. B. Biol. Sci. 270, 689–98CrossRefGoogle ScholarPubMed
Mead, S., Stumpf, M., and Whitfield, J. (2003) Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300, 640–3CrossRefGoogle ScholarPubMed
Carter, R., and Mendis, K. N. (2002) Evolutionary and historical aspects of the burden of malaria. Clin. Microbiol. Rev. 15, 564–94CrossRefGoogle ScholarPubMed
Spielman, A., and D'Antonio, M. (2001) Mosquito: The story of mans deadliest foe. Faber and Faber
Gubler, D. J., (2004) Cities spawn epidemic dengue viruses. Nature, Medicine 10, 129–30CrossRefGoogle ScholarPubMed
Packard, R. M., and Gadehla, P. (1997) A land filled with mosquitoes: Fred L. Soper, the Rockefeller Foundation, and the anopheles gambiae invasion of Brazil. Med. Anthropol. 17, 215–38CrossRefGoogle Scholar
Zajtchuk, R. (1997) Textbook of military medicine: Medical aspects of chemical and biological warfare. http://www.vnh.org/MedAspChemBioWar/ chapters
Meselson, M.. (1994) The Sverdlovsk anthrax outbreak of 1979. Science 266, 1202–8CrossRefGoogle ScholarPubMed
Henderson, D. A. (1999) The looming threat of bioterrorism. Science 283, 1279–82CrossRefGoogle ScholarPubMed
Check, E. (2002) Poliovirus advance sparks fears of data curbs. Nature 418, 265Google ScholarPubMed
Sneador, W. (1985) Drug discovery: The evolution of modern medicines. Wiley
Tulp, M., and Bohlin, L. (2002) Functional versus chemical diversity: Is biodiversity important for drug discovery? Trends Pharmacol. Sci. 23, 225–31CrossRefGoogle ScholarPubMed
Plunkett, M. J., and Ellman, J. A. (1997) Combinatorial chemistry and new drugs. Sci. Am. 276, 68–73CrossRefGoogle ScholarPubMed
Moellering, R. C. Jr. (1999) A novel antimicrobial agent joins the battle against resistant bacteria. Ann. Intern. Med. 130, 155–7CrossRefGoogle ScholarPubMed
Haseltine, W. A. (2001) Beyond chicken soup. Sci. Am. 285, 56–63CrossRefGoogle ScholarPubMed
Fabbro, D.. (2002) Protein kinases as targets for anticancer agents: From inhibitors to useful drugs. Pharmacol. Ther. 93, 79–98CrossRefGoogle ScholarPubMed
Pfeffer, N. (1993) The stork and the syringe: A political history of reproductive medicine. Polity Press
Pilcher, H. (2003) The ups and downs of Lithium. Nature 425, 118–120CrossRefGoogle ScholarPubMed
Healy, D. (2003) The creation of psychopharmacology. Harvard University Press
Bodenheimer, T. (2000) Uneasy alliance – clinical investigators and the pharmaceutical industry. N. Engl. J. Med. 342, 1539–44CrossRefGoogle ScholarPubMed
Dyer, O. (2001) University accused of violating academic freedom to safeguard funding from drug companies. BMJ 323, 591CrossRefGoogle ScholarPubMed
Safer, D. J. (2000) Are stimulants overprescribed for youths with ADHD?Ann. Clin. Psychiatry 12, 55–62CrossRefGoogle ScholarPubMed
Vane, J. (1994) Towards a better aspirin. Nature 367, 215–16CrossRefGoogle ScholarPubMed
Editorial. (2003) How a statin might destroy a drug company. The Lancet 361, 793CrossRef
Henry, D., and Lexchin, J. (2002) The pharmaceutical industry as a medicines provider. The Lancet 16, 1590–5CrossRefGoogle Scholar
Alper, J. (2003) Biotech thinking comes to academic medical centres. Science 299, 1303–5CrossRefGoogle Scholar
Goeddel, D. V., and Levinson, A. D. (2000) Robert A. Swanson (1947–99). Nature 403, 264CrossRefGoogle Scholar
Hall, S., (1988) Invisible frontiers. Atlantic
Vajo, Z., Fawcett, J., and Duckworth, W. C. (2001) Recombinant DNA technology in the treatment of diabetes: Insulin analogs. Endocr. Rev. 22, 706–17CrossRefGoogle ScholarPubMed
Barinaga, M. (2000) Asilomar revisited: Lessons for today? Science 287, 1584–5CrossRefGoogle ScholarPubMed
Kornberg, A. (1995) The golden helix: Inside biotech ventures. University Science Books
Dalton, R., and Schiermeier, Q. (1999) Genentech pays $200m over growth hormone ‘theft’. Nature 402, 335CrossRefGoogle Scholar
Maeder, T. (2003) The orphan drug backlash. Sci. Am. 288, 70–7CrossRefGoogle ScholarPubMed
Lahteenmaki, R., and Fletcher, L. (2002) Public biotechnology 2001 – the numbers. Nat. Biotechnol. 20, 551–5CrossRefGoogle ScholarPubMed
Agres, T. (2003) Licenses worth a billion. The Scientist 17, 55Google Scholar
Ziomek, C., (1998) Commercialisation of proteins produced in the mammary gland. Theriogeniology 49, 139CrossRefGoogle Scholar
Steinberg, F. M., and Raso, J. (1998) Biotech pharmaceuticals and biotherapy: An overview. J. Pharm. Pharm. Sci. 1, 48–59Google ScholarPubMed
Ezzell, C. (2001) Magic bullets fly again. Sci. Am. 285, 34–41CrossRefGoogle Scholar
Stevens, D. L.. (1996) Group A streptococcal bacteremia: The role of tumor necrosis factor in shock and organ failure. J. Infect. Dis. 173, 619–26CrossRefGoogle Scholar
Inoue, N., Takeuchi, M., Ohashi, H., and Suzuki, T. (1995) The production of recombinant human erythropoietin. Biotechnol. Annu. Rev. 1, 297–313CrossRefGoogle ScholarPubMed
Pfeffer, L.. (1998) Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58, 2489–99Google ScholarPubMed
Gutterman, J. (1994) Cytokine therapeutics: Lessons from interferon alpha. Proc. Nat'l. Acad. Sci. 91, 1198–1205CrossRefGoogle ScholarPubMed
Brown, J. B. (1986) Gonadotrophins. In Infertility: Male and Female, ed. V. Insier and B. Lunenfield. Churchill Livingston, pp. 000–000
Laffan, M., and Tuddenham, E. (1998) Science, medicine, and the future: Assessing thrombotic risk. BMJ 317, 520–3CrossRefGoogle ScholarPubMed
DeFrancesco, L. (2001) First sepsis drug nears market. Nature 7, 516–17Google ScholarPubMed
Lu, Y.. (2001) Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation 104, 594–9CrossRefGoogle ScholarPubMed
Griffioen, A. W., and Molema, G. (2000) Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52, 237–68Google ScholarPubMed
Li, R. H., and Wozney, J. M. (2001) Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol. 19, 255–65CrossRefGoogle ScholarPubMed
Teitelbaum, S. L., and Ross, F. P. (2003) Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638–49CrossRefGoogle ScholarPubMed
Chiurel, M. (2000) Whatever happened to leptin. Nature 404, 538–40CrossRefGoogle Scholar
Mattson, M. P. (2001) Lose weight STAT: CNTF tops leptin. TINS 24, 313–14Google ScholarPubMed
Tomalin, C. (2002) Samuel Pepys: The unequalled self. Penguin Viking
Hess, J., and Schmidt, P. (1984) The first blood banker: Oswald Hope Robertson. Transfusion 24, 404–7Google Scholar
Obituary. (2000) Rene Favaloro. The Times (London), July 31
Green, H. (1991) Cultured cells for the treatment of disease. Sci. Am. 265, 96–102CrossRefGoogle Scholar
Petit-Zeman, S. (2001) Regenerative medicine. Nature Biotechnology 19, 201–6CrossRefGoogle ScholarPubMed
Rodan, G. M., TJ. (2000) Therapeutic approaches to bone diseases. Science 289, 1508CrossRefGoogle ScholarPubMed
Lindahl, A., Brittberg, M., and Peterson, L. (2003) Cartilage repair with chondrocytes: Clinical and cellular aspects. Novartis Found. Symp. 249, 175–86Google ScholarPubMed
Oberpenning, F., Meng, J., Yoo, J. J., and Atala, A. (1999) De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat. Biotechnol. 17, 149–55CrossRefGoogle ScholarPubMed
Griffith, L. G., and Naughton, G. (2002) Tissue engineering – current challenges and expanding opportunities. Science 295, 1009–14CrossRefGoogle ScholarPubMed
Dynes, M. (2003) Heart transplant secret of the hospital gardiner. The Times (London), April 26
Dyer, C. (1999) English teenager given heart transplant against her will. BMJ 319, 209CrossRefGoogle ScholarPubMed
Mayes, T. (2003) Ailing tycoon buys Pakistan girl's kidney. The Sunday Times (London), March 23
Mufson, S. (2001) Chinese doctor tells of organ removals after executions. Washington Post, June 27, p. A1
Platt, J. L. (2000) Xenotransplantation: New risks, new gains. Nature 407, 27, 29–30CrossRefGoogle ScholarPubMed
Buhler, L.. (2001) Transplantation of islets of Langerhans: New developments. Swiss Med. Wkly. 131, 671–80Google Scholar
Lumelsky, N.. (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389–94CrossRefGoogle ScholarPubMed
Good, R. A., Gatti, R. A., Hong, R., and Meuwissen, H. J. (1969) Graft treatment of immunological deficiency. Lancet 1, 1162Google ScholarPubMed
Good, R. (1971) Immunodeficiency in developmental perspective. The Harvey Lectures, series 67, 1–107
Parkman, R. (1986) The application of bone marrow transplantation to the treatment of genetic diseases. Science 232, 1373–8CrossRefGoogle ScholarPubMed
Gluckman, E.. (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321, 1174–8CrossRefGoogle Scholar
Barinaga, M. (2000) Fetal neuron grafts pave the way for stem cell therapies. Science 287, 1421–2CrossRefGoogle ScholarPubMed
Li, Y., Field, P., and Raisman, G. (1997) Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 277, 2000–2CrossRefGoogle ScholarPubMed
Thomson, J. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–7CrossRefGoogle ScholarPubMed
Marshall, E. (2000) The business of stem cells. Science 287, 1419–21CrossRefGoogle ScholarPubMed
Aldous, P. (2001) Can they rebuild this? Nature 410, 622–5CrossRefGoogle Scholar
Manouvrier-Hanu, S., Holder-Espinasse, M., and Lyonnet, S. (1999) Genetics of limb anomalies in humans. TIGS 15, 409–17CrossRefGoogle ScholarPubMed
Eldadah, Z. A.. (2001) Familial tetralogy of fallot caused by mutation in the jagged gene. Hum. Mol. Genet. 10, 163–9CrossRefGoogle Scholar
Rosner, F. (1969) Hemophilia in the Talmud and rabbinic writings. Ann. Intern. Med. 70, 833–7CrossRefGoogle ScholarPubMed
Roth, E. F., Raventos-Suarez, C., Rinaldi, A., and Nagel, R. L. (1983) Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 80, 298–9CrossRefGoogle ScholarPubMed
Chakravarti, A., and Chakraborty, R. (1978) Elevated frequency of Tay-Sachs disease among Ashkenazic Jews unlikely by genetic drift alone. Am. J. Hum. Genet. 30, 256–61Google ScholarPubMed
Hogenauer, C.. (2000) Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: An evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am. J. Hum. Genet. 67, 1422–7CrossRefGoogle ScholarPubMed
Kuper, A. (2003) Incest, cousin marriage, and the origin of the human sciences in the nineteenth century. Past and Present Society 174, 155–83Google Scholar
Gibbons, A. (1993) The risks of inbreeding. Science 259, 1252CrossRefGoogle ScholarPubMed
Cao, A., and Rosatelli, M. C. (1993) Screening and prenatal diagnosis of the haemoglobinopathies. Baillieres Clin. Haematol. 6, 263–86CrossRefGoogle ScholarPubMed
Modell, B., and Darr, A. (2002) Genetic counselling and customary consanguineous marriage. Nature, Genetics 3, 225–9CrossRefGoogle ScholarPubMed
Kaback, M. M. (2001) Screening and prevention in Tay-Sachs disease: Origins, update, and impact. Adv. Genet. 44, 253–65Google ScholarPubMed
Ekstein, J., and Katzenstein, H. (2001) The Dor Yeshorim story: Community-based carrier screening for Tay-Sachs disease. Adv. Genet. 44, 297–310Google ScholarPubMed
Handyside, A. H., Kontogianni, E. H., Hardy, K., and Winston, R. M. (1990) Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 344, 768–70CrossRefGoogle ScholarPubMed
Rifkin, J., (1998) The biotech century. Victor Gollanz
Editorial. (1994) China's misconception of eugenics. Nature 367, 3
Kumar, S. (2003) Ratio of girls to boys in India continues to decline. BMJ 327, 1007CrossRefGoogle Scholar
Crockin, S. (2001) Adam Nash: Legally speaking, a happy ending or slippery slope? Reprod. Biomed. Online 2, 6–7CrossRefGoogle ScholarPubMed
Levy, N. (2002) Deafness, culture and choice. J. Med. Ethics 28, 284–5CrossRefGoogle Scholar
Shakespeare, T. (2003) How perfect do we want our babies to be?, The Sunday Times (London), November 23
Dyer, C. (2000) Appeal court bars sterilisation of woman with learning disabilities. The Guardian, May 19
Papadopoulos, G. K., Wijmenga, C., and Koning, F. (2001) Interplay between genetics and the environment in the development of celiac disease: Perspectives for a healthy life. J. Clin. Invest. 108, 1261–6CrossRefGoogle ScholarPubMed
Cohen, F. E. and Kelly, J. W. (2003) Therapeutic approaches to protein misfolding diseases. Nature 426, 405–9CrossRefGoogle ScholarPubMed
Anderson, W. F. (1992) Human gene therapy. Science 256, 808–13CrossRefGoogle ScholarPubMed
Williams, D., and Baum, C. (2003) Medicine: Gene therapy – new challenges ahead. Science 302, 400–1CrossRefGoogle ScholarPubMed
Ferber, D. (2001) Gene therapy: Safer and virus-free? Science 294, 1638–42CrossRefGoogle ScholarPubMed
Stock, G., and Campbell, J., (2000) Engineering the human germline: An exploration of the science and ethics of altering the genes we pass to our children. Oxford University Press
Lindee, M. (2003) Watson's world. Science 300, 432–4CrossRefGoogle Scholar
McLaren, A. (1998) Correspondence. Nature 392, 645CrossRefGoogle Scholar
Nielsen, T. (1997) Human germline therapy. McGill Journal of Medicine 3, 126–132Google Scholar
Peltonen, L., and McKusick, V. A. (2001) Genomics and medicine: Dissecting human disease in the postgenomic era. Science 291, 1224–9CrossRefGoogle ScholarPubMed
Evans, W. E., and Relling, M. V. (1999) Pharmacogenomics: Translating functional genomics into rational therapeutics. Science 286, 487–91CrossRefGoogle ScholarPubMed
Wolf, C., Smith, G., and Smith, R. L. (2000) Science, medicine, and the future: Pharmacogenetics. BMJ 320, 987CrossRefGoogle ScholarPubMed
Mossialos, E., and Dixon, A. (2001) Genetic testing and insurance: Opportunities and challenges for society. Trends Mol. Med. 7, 323–4CrossRefGoogle ScholarPubMed
Ridley, M. (1999) Genome: The autobiography of a species in 23 chapters. Fourth Estate
Appleyard, B. (1999) Brave new worlds. HarperCollins
Charatan, F. (2001) US spending on prescription drugs rose by 19% in 2000. BMJ 322, 1198Google Scholar
Gottlieb, S. (2002) Congress criticises drugs industry for misleading advertising. BMJ 325, 1379CrossRefGoogle ScholarPubMed
Binswanger, H. (2003) HIV/AIDS treatment for millions. Science 292, 221CrossRefGoogle Scholar
Cohen, J. (2003) Companies, donor's pledge to close gap in AIDS treatment. Science 289, 368CrossRefGoogle Scholar
Caplan, A. (2004) Is biomedical research too dangerous to pursue? Science 303, 1142CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • References
  • Michael G. Sargent, National Institute for Medical Research, London
  • Book: Biomedicine and the Human Condition
  • Online publication: 06 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511546419.017
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • References
  • Michael G. Sargent, National Institute for Medical Research, London
  • Book: Biomedicine and the Human Condition
  • Online publication: 06 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511546419.017
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • References
  • Michael G. Sargent, National Institute for Medical Research, London
  • Book: Biomedicine and the Human Condition
  • Online publication: 06 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511546419.017
Available formats
×